GLP-1 Market
LLY $1208.74 ▲ +3.6% NVO $38.12 ▲ +0.2% PFE $29.21 ▲ +3.0% VKTX $25.47 ▼ -4.4% KLRA $10.74 ▼ -0.3% GPCR $21.88 ▼ -1.9% RHHBY $55.67 ▲ +3.5%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Angiotensin Ii

Company
Amy Arnold
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
103 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

103 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 15, 2026

Find a Clinical Trial Near Me

See recruiting studies for Angiotensin Ii and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02378805

    Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

    University Hospital Goettingen 800 participants Est. completion 2036-03-01 1 site
    Other conditions: Alport Syndrome, Hereditary Kidney Disease, Pediatric Kidney Disease, Thin Basement Membrane Disease, Familial Benign Hematuria
    View official trial listing →
  • Recruiting NCT NCT02472028

    Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals

    Not yet reported Assistance Publique - Hôpitaux de Paris 820 participants Est. completion 2028-09-11 2 sites Stand-alone
    Other conditions: Cerebrovascular Disorders
    View official trial listing →
  • Recruiting NCT NCT02560805

    Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

    Not yet reported Emory University 134 participants Est. completion 2027-03-30 1 site
    Other conditions: Stress Disorders, Post-Traumatic
    View official trial listing →
  • Recruiting NCT NCT02646475

    Metabolic Effects of Angiotensin-(1-7)

    Not yet reported Vanderbilt University 26 participants Est. completion 2029-12 1 site Stand-alone
    Other conditions: Obesity, Insulin Resistance, Hypertension, Metabolic Cardiovascular Syndrome
    View official trial listing →
  • Recruiting NCT NCT02735707

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

    Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
    Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
    View official trial listing →
  • Recruiting NCT NCT02770066

    A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension

    University of Aarhus 160 participants Est. completion 2035-01 5 sites
    Cardiovascular disease Other conditions: Renal Artery Obstruction, Hypertension, Renovascular, Kidney Diseases
    View official trial listing →
  • Recruiting NCT NCT02818517

    Evaluation and Management of Cardio Toxicity in Oncologic Patients

    Tel-Aviv Sourasky Medical Center 1000 participants Est. completion 2031-12-31 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT02842424

    Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

    Not yet reported University of Nebraska 70 participants Est. completion 2026-06 1 site
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Recruiting NCT NCT02966665

    : Vascular Function in Health and Disease

    Not yet reported D. Walter Wray 420 participants Est. completion 2030-08 1 site Stand-alone
    Heart failure Other conditions: Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension, Hypertension
    View official trial listing →
  • Recruiting NCT NCT03593317

    Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD

    Not yet reported Hospices Civils de Lyon 120 participants Est. completion 2029-12 13 sites
    Other conditions: Arrhythmogenic Right Ventricular Dysplasia
    View official trial listing →
  • Recruiting NCT NCT03770702

    Statins and ARBs on Rheumatoid Activity

    Not yet reported Sherief Abd-Elsalam 45 participants Est. completion 2026-12-01 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT03770936

    Effect of Some Drugs on Liver Fibrosis

    Not yet reported Sherief Abd-Elsalam 45 participants Est. completion 2027-11 1 site
    Other conditions: Liver Fibroses
    View official trial listing →
  • Recruiting NCT NCT03806283

    Mechanisms of Pregnancy Vascular Adaptations

    University of Wisconsin, Madison 166 participants Est. completion 2027-04 1 site
    Other conditions: Pre-Eclampsia, Vascular Diseases
    View official trial listing →
  • Recruiting NCT NCT04162444

    Results of the Aortic Valve Reconstruction in Children

    National Medical Research Center for Children's Health, Russian Federation 40 participants Est. completion 2027-10 1 site
    Other conditions: Aortic Valve Insufficiency
    View official trial listing →
  • Recruiting NCT NCT04183101

    Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

    Not yet reported Region Skane 30 participants Est. completion 2029-12 4 sites
    Other conditions: C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality, Dense Deposit Disease, C3 Glomerulonephritis
    View official trial listing →
  • Recruiting NCT NCT04191681

    Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

    Not yet reported The Cleveland Clinic 50 participants Est. completion 2022-12 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT04286399

    Asian Diabetes Outcomes Prevention Trial

    Not yet reported National Heart Centre Singapore 2400 participants Est. completion 2034-06-30 1 site
    Cardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT04367883

    Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

    Consorci Sanitari de Terrassa 3000 participants Est. completion 2028-02-24 1 site
    Other conditions: COVID19, Influenza Vaccination, ACE Inhibitors, ARB, Antihistamine Allergy, Amantadine
    View official trial listing →
  • Recruiting NCT NCT04456816

    A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

    Not yet reported SynAct Pharma Aps 23 participants Est. completion 2026-06-30 1 site
    Other conditions: Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04520048

    Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women

    Not yet reported Assistance Publique - Hôpitaux de Paris 110 participants Est. completion 2026-12 3 sites Stand-alone
    Other conditions: Hypertension Disorders in Pregnancy, Gestational Hypertension, Pre-Eclampsia
    View official trial listing →
  • Recruiting NCT NCT04662723

    Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

    Not yet reported Fondazione Schena 878 participants Est. completion 2028-12-31 2 sites Stand-alone
    Other conditions: Glomerulonephritis, Immunoglobulin A Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04680442

    Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction

    Not yet reported Population Health Research Institute 130 participants Est. completion 2026-06-30 8 sites Stand-alone
    Heart failure Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04715568

    Secondhand Tobacco Smoke and Cardiovascular Disease

    Not yet reported University of California, San Francisco 100 participants Est. completion 2026-12-31 1 site
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT04752293

    Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

    Wake Forest University Health Sciences 125 participants Est. completion 2026-12 1 site
    Other conditions: Hypertension, Left Ventricular Hypertrophy, Left Ventricular Dysfunction, Left Atrial Dilatation, Left Ventricular Diastolic Dysfunction, Kidney Diseases, Kidney Injury, Kidney Dysfunction, Sodium Urine High, Blood Pressure Disorders, Uric Acid Retention, Angiotensin Hypertension, Autonomic Dysfunction, Autonomic Imbalance, Pediatric Kidney Disease, Pediatric Obesity, Proteinuria, Albuminuria
    View official trial listing →
  • Recruiting NCT NCT04763577

    Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema

    University Hospital, Grenoble 243 participants Est. completion 2025-10-26 4 sites
    Other conditions: Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
    View official trial listing →
  • Recruiting NCT NCT04768322

    LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients

    Not yet reported Hospices Civils de Lyon 92 participants Est. completion 2029-02 8 sites Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT04849806

    Sympathetic Nerve Activity Predictors in Patients With Chronic Obstructive Pulmonary Disease

    RWTH Aachen University 135 participants Est. completion 2028-12 1 site
    Other conditions: COPD, Sympathetic Nervous System Diseases, Catecholamine; Overproduction
    View official trial listing →
  • Recruiting NCT NCT04864145

    Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation

    Not yet reported Nanjing First Hospital, Nanjing Medical University 210 participants Est. completion 2031-05-30 1 site
    Other conditions: Aortic Valve Disease
    View official trial listing →
  • Recruiting NCT NCT04884802

    The GUARDIAN Trial

    Not yet reported The University of Texas Health Science Center, Houston 6254 participants Est. completion 2027-04-25 20 sites Stand-alone
    Other conditions: Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT04913870

    Angiotensin Receptor Blockers in Aortic Stenosis

    Not yet reported Institut universitaire de cardiologie et de pneumologie de Québec, University Laval 144 participants Est. completion 2027-02 2 sites Stand-alone
    Other conditions: Aortic Stenosis, Aortic Valve Stenosis
    View official trial listing →
  • Recruiting NCT NCT04962711

    Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

    Not yet reported Baker Heart and Diabetes Institute 685 participants Est. completion 2025-12-31 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT04971720

    PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

    Not yet reported, Not yet reported University of Alabama at Birmingham 160 participants Est. completion 2027-01-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Obesity, Hypertension, Nocturnal Blood Pressure, Natriuretic Peptides, Renin-Angiotensin-Aldosterone System
    View official trial listing →
  • Recruiting NCT NCT04977180

    Cardioprotection in AML

    Not yet reported University of Virginia 70 participants Est. completion 2028-09 1 site
    Other conditions: AML, Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT04983823

    Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

    Not yet reported Baker Heart and Diabetes Institute 820 participants Est. completion 2025-12-30 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT05106036

    Preventing Cognitive Decline by Reducing BP Target Trial

    Not yet reported University of Texas Southwestern Medical Center 4000 participants Est. completion 2026-08-31 1 site Stand-alone
    Other conditions: Cognitive Decline, Blood Pressure, Hypertension
    View official trial listing →
  • Recruiting NCT NCT05180773

    Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

    Not yet reported Dennis M. McNamara, MD, MS 250 participants Est. completion 2028-12-31 64 sites
    Other conditions: Peripartum Cardiomyopathy, Postpartum
    View official trial listing →
  • Recruiting NCT NCT05183646

    A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

    Not yet reported Dimerix Bioscience Pty Ltd 286 participants Est. completion 2029-12 220 sites
    Other conditions: FSGS
    View official trial listing →
  • Recruiting NCT NCT05442463

    Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

    University of Calgary 200 participants Est. completion 2025-11-30 1 site
    Other conditions: Hormone Therapy
    View official trial listing →
  • Recruiting NCT NCT05457283

    A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

    Not yet reported Bayer 100 participants Est. completion 2028-08-31 151 sites
    Chronic kidney disease Other conditions: Proteinuria, Children
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Recruiting NCT NCT05530655

    A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

    Not yet reported University of Rochester 30 participants Est. completion 2028-01-01 1 site
    Other conditions: Prostate Cancer, Radiation Toxicity, Urinary Complication
    View official trial listing →
  • Recruiting NCT NCT05726916

    Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

    Not yet reported Assistance Publique - Hôpitaux de Paris 66 participants Est. completion 2027-11-09 1 site Stand-alone
    Other conditions: Hypertensive Emergency-associated Hemolytic Uremic Syndrome
    View official trial listing →
  • Recruiting NCT NCT05764057

    DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction

    Not yet reported Assistance Publique - Hôpitaux de Paris 450 participants Est. completion 2026-10-12 1 site Stand-alone
    Other conditions: AMI, STEMI, NSTEMI, Left Ventricular Dysfunction
    View official trial listing →
  • Recruiting NCT NCT05780710

    OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake

    Not yet reported Aktiia SA 35 participants Est. completion 2026-12-31 3 sites
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT05834803

    Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.

    Not yet reported University of Aarhus 80 participants Est. completion 2027-06-01 3 sites
    Heart failure Other conditions: Renovascular Hypertension, Renovascular Hypertension With Renal Failure, Renal Artery Stenosis Atherosclerotic, Percutaneous Transluminal Angioplasty
    View official trial listing →
  • Recruiting NCT NCT05839314

    Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

    Not yet reported Chinese PLA General Hospital 480 participants Est. completion 2027-07-01 1 site Stand-alone
    Other conditions: Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT05855746

    Colchicine Versus Placebo in Acute Myocarditis Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 300 participants Est. completion 2028-07-16 2 sites Stand-alone
    Other conditions: Acute Myocarditis
    View official trial listing →
  • Recruiting NCT NCT05937841

    Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia

    Not yet reported Anna Stanhewicz, PhD 30 participants Est. completion 2026-06-01 1 site
    Other conditions: Preeclampsia Postpartum
    View official trial listing →
  • Recruiting NCT NCT05942027

    Role of Coenzyme Q10 in Chronic Kidney Disease

    Not yet reported Tanta University 44 participants Est. completion 2026-07-15 1 site
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT05942053

    Role of Vitamin K2 in Chronic Kidney Disease

    Not yet reported Tanta University 44 participants Est. completion 2026-07-15 1 site
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT06023576

    A Study of Blood Pressure Control During Cancer Treatment

    Not yet reported Memorial Sloan Kettering Cancer Center 130 participants Est. completion 2029-05-30 7 sites Stand-alone
    Other conditions: Breast Cancer, Cardiotoxicity
    View official trial listing →
  • Recruiting NCT NCT06150560

    A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

    Not yet reported Mayo Clinic 120 participants Est. completion 2028-06-01 1 site
    Other conditions: Coarctation of Aorta, High Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06183437

    The STOP-MED CTRCD Trial

    Not yet reported Dinesh Thavendiranathan 335 participants Est. completion 2031-12 14 sites Stand-alone
    Heart failure Other conditions: Cardiotoxicity, Cardiac Toxicity, Antineoplastics Toxicity, Cancer
    View official trial listing →
  • Recruiting NCT NCT06218199

    Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

    Not yet reported Heart Center Research, LLC 80 participants Est. completion 2026-12-31 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06234592

    The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock

    Not yet reported King's College Hospital NHS Trust 45 participants Est. completion 2026-07 1 site Stand-alone
    Other conditions: Septic Shock, Acute Kidney Injury
    View official trial listing →
  • Recruiting NCT NCT06256991

    Potassium Correction for RAAS Optimization in Chronic Kidney Disease

    Not yet reported University Medical Center Groningen 44 participants Est. completion 2027-12 1 site
    Chronic kidney disease Other conditions: Hyperkalemia, Hypertension
    View official trial listing →
  • Recruiting NCT NCT06282965

    Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury

    Not yet reported, Not yet reported University of Arizona 90 participants Est. completion 2027-09 1 site Stand-alone
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Recruiting NCT NCT06351150

    Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 214 participants Est. completion 2027-12 42 sites Stand-alone
    Other conditions: Vasodilatory Shock
    View official trial listing →
  • Recruiting NCT NCT06482853

    Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension

    Not yet reported Milton S. Hershey Medical Center 52 participants Est. completion 2029-03 1 site Stand-alone
    Other conditions: Obesity, Hypertension
    View official trial listing →
  • Recruiting NCT NCT06487585

    ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)

    Not yet reported University of Maryland St. Joseph Medical Center 100 participants Est. completion 2026-02 1 site
    Other conditions: Vasodilatory Hypotension During or After Cardiac Surgery
    View official trial listing →
  • Recruiting NCT NCT06539234

    Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II.

    University Medical Centre Maribor 121 participants Est. completion 2027-09-01 2 sites
    Other conditions: Shock, Vasoplegic Syndrome
    View official trial listing →
  • Recruiting NCT NCT06562582

    STunning in Acute Myocardial Infarction - BAS

    Not yet reported Vastra Gotaland Region 120 participants Est. completion 2027-12-31 1 site
    Other conditions: Myocardial Infarct
    View official trial listing →
  • Recruiting NCT NCT06615102

    Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II

    Not yet reported Universität Münster 1022 participants Est. completion 2027-04 4 sites Stand-alone
    Other conditions: Cardiac Surgery, Vasoplegia
    View official trial listing →
  • Recruiting NCT NCT06625346

    Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

    The Searle Company Limited Pakistan 420 participants Est. completion 2025-09-15 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06654596

    Efficacy and Safety of Telitacicept in IgAN

    Not yet reported Ruijin Hospital 118 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: IgA Nephropathy (IgAN), Kidney Diseases, Telitacicept, Glucocorticoid
    View official trial listing →
  • Recruiting NCT NCT06655480

    Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

    Not yet reported National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50 participants Est. completion 2027-12-31 1 site
    Heart failure Other conditions: LVDD, Myocardial Fibrosis
    View official trial listing →
  • Recruiting NCT NCT06676384

    Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

    Not yet reported Christian Medical College, Vellore, India 585 participants Est. completion 2029-08 12 sites
    Other conditions: IgA Nephropathy, Renal Insufficiency, Chronic, IgA Vasculitis, IGA Glomerulonephritis
    View official trial listing →
  • Recruiting NCT NCT06693726

    Early Angiotensin II in the Emergency Department

    Not yet reported Brett A Faine 20 participants Est. completion 2027-01-30 1 site Stand-alone
    Other conditions: Septic Shock
    View official trial listing →
  • Recruiting NCT NCT06704633

    Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania

    Not yet reported Martin Rohacek 298 participants Est. completion 2028-11-30 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06711432

    Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients(PRECISION)

    Not yet reported Zhejiang Cancer Hospital 214 participants Est. completion 2026-06-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Tumor
    View official trial listing →
  • Recruiting NCT NCT06749418

    Vascular Effects of High-Salt After Preeclampsia

    Not yet reported Anna Stanhewicz, PhD 40 participants Est. completion 2027-11-15 1 site Stand-alone
    Other conditions: Preeclampsia, Preeclampsia Postpartum
    View official trial listing →
  • Recruiting NCT NCT06838416

    Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease

    Second Affiliated Hospital of Soochow University 300 participants Est. completion 2026-12-31 1 site
    Type 2 diabetesChronic kidney disease Other conditions: Renal Function
    View official trial listing →
  • Recruiting NCT NCT06853951

    Cardioprotection on Chemotherapy-Induced Cardiotoxicity

    Not yet reported Ain Shams University 30 participants Est. completion 2025-07-18 2 sites
    Other conditions: Cardiotoxicity
    View official trial listing →
  • Recruiting NCT NCT06890143

    The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children

    Not yet reported Children's Hospital of Fudan University 44 participants Est. completion 2027-03-31 1 site Stand-alone
    Other conditions: Pediatric Hereditary Kidney Diseases
    View official trial listing →
  • Recruiting NCT NCT06917664

    Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

    Not yet reported China National Center for Cardiovascular Diseases 220 participants Est. completion 2027-06 1 site
    Cardiovascular disease Other conditions: Ischemic Mitral Regurgitation, Angiotensin Receptor/Neprilysin Inhibitor
    View official trial listing →
  • Recruiting NCT NCT06918756

    Development of a Cough Control Questionnaire (CCQ)

    King's College Hospital NHS Trust 100 participants Est. completion 2031-09-01 1 site
    Other conditions: Cough
    View official trial listing →
  • Recruiting NCT NCT06930092

    RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy

    Not yet reported Seoul National University Hospital 158 participants Est. completion 2029-04-30 1 site
    Other conditions: Ischemic Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT06933706

    Losartan to Improve Outcomes After Multi-ligament Knee Injury

    Not yet reported Brigham and Women's Hospital 90 participants Est. completion 2029-09-30 3 sites Stand-alone
    Other conditions: Multi-ligament Knee Injury
    View official trial listing →
  • Recruiting NCT NCT06952608

    Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 140 participants Est. completion 2026-04-10 1 site
    Other conditions: Intraoperative Hypotension, Ciprofol, Renin-angiotensin System Inhibitors
    View official trial listing →
  • Recruiting NCT NCT06975111

    Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

    Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites
    Other conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
    View official trial listing →
  • Recruiting NCT NCT07099677

    Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk

    Not yet reported Abant Izzet Baysal University 186 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: Hypertension, Fall Risk, Postural Balance, Fear of Falling
    View official trial listing →
  • Recruiting NCT NCT07099859

    Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.

    Not yet reported Vitor Emer Egypto Rosa 60 participants Est. completion 2029-07-01 1 site
    Heart failure Other conditions: Heart Valve Diseases, Left Ventricle Remodeling, Aortic Regurgitation Disease, Natriuretic Peptide, Brain
    View official trial listing →
  • Recruiting NCT NCT07167368

    Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients

    Not yet reported Haiyan Pan 60 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Cardiorenal Syndrome
    View official trial listing →
  • Recruiting NCT NCT07169422

    Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care

    Not yet reported Nova Scotia Health Authority 120 participants Est. completion 2028-07-01 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07181109

    Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

    Not yet reported Alnylam Pharmaceuticals 11000 participants Est. completion 2030-09-23 1190 sites
    Cardiovascular disease Other conditions: Hypertension, High Cardiovascular Risk
    View official trial listing →
  • Recruiting NCT NCT07259512

    Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure

    Not yet reported Evi Liliek Wulandari 80 participants Est. completion 2026-01-31 1 site
    Chronic kidney diseaseHeart failure
    View official trial listing →
  • Recruiting NCT NCT07309094

    Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

    Cardenal Herrera University 250 participants Est. completion 2028-12-31 1 site
    Chronic kidney diseaseType 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07312292

    Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)

    Not yet reported Niek Wijnen 15 participants Est. completion 2027-11-01 1 site Stand-alone
    Other conditions: Liver Cancer (Locally Advanced or Metastatic), Liver Cancer Adult
    View official trial listing →
  • Recruiting NCT NCT07315191

    Finerenone Therapy for Pediatric HSPN With Mild Proteinuria

    Not yet reported Capital Institute of Pediatrics, China 116 participants Est. completion 2028-04-30 1 site
    Other conditions: Henoch Schönlein Purpura Nephritis
    View official trial listing →
  • Recruiting NCT NCT07335900

    A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis

    Not yet reported RenJi Hospital 25 participants Est. completion 2027-05-30 1 site Stand-alone
    Other conditions: Severe Aortic Valve Stenosis
    View official trial listing →
  • Recruiting NCT NCT07347925

    Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF

    Future University in Egypt 140 participants Est. completion 2026-05-01 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07355023

    AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Target Trial Emulation Study

    Not yet reported Tri-Service General Hospital (TSGH) 5000 participants Est. completion 2026-01-15 1 site Stand-alone
    Other conditions: Left Ventricular (LV) Systolic Dysfunction
    View official trial listing →
  • Recruiting NCT NCT07444203

    Transformative Research in Diabetic Nephropathy 2.0

    University of Pennsylvania 200 participants Est. completion 2028-11-12 1 site
    Type 2 diabetes Other conditions: Diabetic Nephropathies, Kidney Diseases, Renal Insufficiency, Chronic
    View official trial listing →
  • Recruiting NCT NCT07458880

    Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control

    Not yet reported The University of Hong Kong 140 participants Est. completion 2030-06-30 4 sites
    Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT07513883

    The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

    Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07560982

    Evaluating Adherence to Guideline-Directed Medical Therapy in Patients With Advanced Heart Failure

    Università Vita-Salute San Raffaele 300 participants Est. completion 2036-07-01 2 sites
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07572032

    Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

    Not yet reported Kyungsub Song 80 participants Est. completion 2028-12-20 4 sites
    Cardiovascular diseaseHeart failure Other conditions: Valvular Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT07631156

    STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

    Not yet reported Kyungsub Song 80 participants Est. completion 2029-12-30 5 sites Stand-alone
    Heart failure Other conditions: Ventricular Dysfunction, Left
    View official trial listing →
  • Recruiting NCT NCT07654140

    A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

    Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 252 participants Est. completion 2027-07-31 1 site
    Other conditions: Uncontrolled Hypertension
    View official trial listing →
  • Recruiting NCT NCT07683585

    Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 207 participants Est. completion 2026-09 1 site
    Other conditions: Hypertension, Coronary Arterial Disease, Percutaneous Coronary Intervention
    View official trial listing →
  • Recruiting NCT NCT07685938

    Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

    Not yet reported UNC Lineberger Comprehensive Cancer Center 60 participants Est. completion 2029-02 1 site Stand-alone
    Other conditions: Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer, Mediastinal Cancers, Spine Metastases, Spinal Tumor, Thoracic Cancer, Thoracic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07734636

    A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury

    Not yet reported University of California, San Francisco 60 participants Est. completion 2029-03 1 site
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Recruiting NCT NCT07758634

    A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension

    Not yet reported, Not yet reported CRISPR Therapeutics AG 69 participants Est. completion 2029-07-01 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00000542

    Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2002-03
    Cardiovascular diseaseHeart failure Other conditions: Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00000558

    Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2005-06
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00001461

    Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme

    National Heart, Lung, and Blood Institute (NHLBI) 209 participants Est. completion 2001-04 1 site
    Other conditions: Atherosclerosis, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00001534

    Long Term Effects of Enalapril and Losartan on Genetic Heart Disease

    National Heart, Lung, and Blood Institute (NHLBI) 112 participants Est. completion 2003-04 1 site
    Other conditions: Hypertrophic Cardiomyopathy, Left Ventricular Hypertrophy, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00001628

    The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 36 participants Est. completion 2000-09 1 site
    Heart failureCardiovascular disease Other conditions: Atherosclerosis, Hypertension
    View official trial listing →
  • Completed NCT NCT00001629

    The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 49 participants Est. completion 2000-09 1 site
    Heart failureCardiovascular disease Other conditions: Atherosclerosis, Hypertension
    View official trial listing →
  • Completed NCT NCT00001741

    Study of Inherited Changes of Receptors Located on Blood Vessels

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 200 participants Est. completion 2003-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00004562

    Occluded Artery Trial (OAT)

    Not yet reported NYU Langone Health 2201 participants Est. completion 2011-06 1 site Stand-alone
    Cardiovascular diseaseHeart failure Other conditions: Heart Diseases
    View official trial listing →
  • Completed NCT NCT00005400

    Angiotensinogen Variants and Adverse Pregnancy Outcomes

    University of Utah Est. completion 2003-07
    Cardiovascular disease Other conditions: Heart Diseases, Pre-Eclampsia
    View official trial listing →
  • Completed NCT NCT00005456

    Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1995-11
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension, Eclampsia, Pre-Eclampsia
    View official trial listing →
  • Completed NCT NCT00005928

    Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2002-02 1 site
    Other conditions: Atherosclerosis, Coronary Disease, Vasculitis
    View official trial listing →
  • Completed NCT NCT00006294

    Genetics of Hypertension Associated Treatments (GenHAT)

    Donna Arnett, 257-5678 37939 participants Est. completion 2005-08 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00006305

    Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes

    Not yet reported University of Pittsburgh 2368 participants Est. completion 2009-03
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Insulin Resistance, Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT00006328

    Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy

    National Center for Research Resources (NCRR) 1 site
    Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT00063492

    Angiotensinogen Gene and Human Hypertension

    University of Utah Est. completion 2007-12
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00067990

    Angiotensin II Blockade for Chronic Allograft Nephropathy

    Not yet reported University of Minnesota 153 participants Est. completion 2011-06 2 sites
    Other conditions: Kidney Disease, Proteinuria
    View official trial listing →
  • Withdrawn NCT NCT00089518

    Optimal Treatment for Kidney Disease in HIV Infected Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 sites
    Other conditions: HIV Infections, Kidney Disease
    View official trial listing →
  • Completed NCT NCT00098137

    Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation

    Not yet reported Atrial Fibrillation Network 422 participants Est. completion 2009-05
    Other conditions: Heart Disease, Arrhythmia, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00106561

    Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

    Not yet reported, Not yet reported Melbourne Health 60 participants Est. completion 2004-09 1 site
    Chronic kidney disease Other conditions: Kidney Disease, Glomerulonephritis, Proteinuria
    View official trial listing →
  • Completed NCT NCT00108082

    The CLEVER Study - Coreg And Left Ventricular Mass Regression

    Not yet reported GlaxoSmithKline 287 participants Est. completion 2008-08 78 sites
    Other conditions: Hypertrophy, Left Ventricular
    View official trial listing →
  • Status unknown NCT NCT00108706

    Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

    Not yet reported City Hospitals Sunderland NHS Foundation Trust 50 participants Est. completion 2007-09 1 site
    Cardiovascular disease Other conditions: Cerebrovascular Accident
    View official trial listing →
  • Completed NCT NCT00113087

    Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 230 participants Est. completion 2008-07 9 sites
    Heart failure Other conditions: Heart Defects, Congenital
    View official trial listing →
  • Terminated NCT NCT00113698

    Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation

    Not yet reported University of Utah 5 participants Est. completion 2006-01 7 sites
    Heart failure Other conditions: Heart Defects, Congenital, Heart Septal Defects, Ventricular
    View official trial listing →
  • Completed NCT NCT00118976

    Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

    Not yet reported Steno Diabetes Center Copenhagen 60 participants Est. completion 2006-09 1 site
    Chronic kidney disease Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Completed NCT NCT00122447

    Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

    Not yet reported Emory University 84 participants Est. completion 2011-05 2 sites
    Prediabetes Other conditions: Prediabetic State
    View official trial listing →
  • Completed NCT NCT00125645

    Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)

    Not yet reported University of Southern Denmark 200 participants Est. completion 2011-09-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00126516

    Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

    Not yet reported Nara Medical University 395 participants Est. completion 2013-06 1 site
    Other conditions: Brain Infarction, Hypertension
    View official trial listing →
  • Completed NCT NCT00129233

    Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance

    Not yet reported Nagoya University 1150 participants Est. completion 2013-04 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00130156

    Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

    Not yet reported Eisai Inc. 93 participants Est. completion 2009-03 1 site
    Other conditions: High Blood Pressure
    View official trial listing →
  • Completed NCT NCT00134160

    OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study

    Not yet reported OSCAR Study 1000 participants Est. completion 2010-05 2 sites
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00135551

    Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

    Not yet reported Seiji Umemoto, M.D., Ph.D. 3501 participants Est. completion 2010-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00141453

    ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

    Not yet reported Daiichi Sankyo Co., Ltd. 577 participants Est. completion 2009-01 2 sites
    Chronic kidney diseaseType 2 diabetes Other conditions: Proteinuria
    View official trial listing →
  • Terminated NCT NCT00141583

    The Renin-Angiotensin System in Essential Hypertension

    Not yet reported St George's, University of London 11 participants Est. completion 2006-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00141778

    Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)

    Not yet reported, Not yet reported Vanderbilt University 455 participants Est. completion 2010-08 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00143949

    Renin Angiotensin System Study (RASS/B-RASS)

    Not yet reported Michael Mauer, MD 285 participants Est. completion 2008-05 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT00144144

    A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes

    Not yet reported Advanced-J 300 participants Est. completion 2008-09 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00149227

    Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

    Not yet reported Kyoto Prefectural University of Medicine 3031 participants Est. completion 2009-01 1 site
    Heart failureCardiovascular disease Other conditions: Hypertension, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00150826

    QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia

    Not yet reported University of Florida 78 participants Est. completion 2004-12 1 site
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00153088

    INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy

    Not yet reported Boehringer Ingelheim 527 participants Est. completion 2005-11 160 sites
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT00153101

    Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

    Not yet reported Boehringer Ingelheim 31546 participants 732 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00154024

    Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.

    Not yet reported Technische Universität Dresden Est. completion 2006-10 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00155064

    Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism

    Not yet reported National Taiwan University Hospital 100 participants Est. completion 2005-12 1 site
    Other conditions: Hyperaldosteronism
    View official trial listing →
  • Completed NCT NCT00155246

    Efficacy of Pentoxifylline on Chronic Kidney Disease

    Not yet reported National Taiwan University Hospital 60 participants Est. completion 2007-01 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00155779

    ACE Gene Polymorphism and ARDS Outcome

    National Taiwan University Hospital 250 participants Est. completion 2004-12 1 site
    Other conditions: Adult Respiratory Distress Syndrome
    View official trial listing →
  • Completed NCT NCT00157729

    MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)

    Not yet reported Medicure 160 participants Est. completion 2005-07 1 site
    Type 2 diabetesMetabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00159588

    Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?

    Not yet reported Norwegian University of Science and Technology 64 participants Est. completion 2007-12 1 site
    Other conditions: Headache
    View official trial listing →
  • Completed NCT NCT00162955

    Prevention of CHOP-induced Chronic Cardiotoxicity

    Not yet reported Osaka City University 150 participants Est. completion 2010-09 1 site
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00170924

    To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.

    Not yet reported Novartis 317 participants Est. completion 2006-06 1 site
    Other conditions: Diastolic Dysfunction, Hypertension
    View official trial listing →
  • Completed NCT NCT00172276

    Angiotensin Converting Enzyme Gene Polymorphism in Children With Idiopathic Nephrotic Syndrome

    National Taiwan University Hospital
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Status unknown NCT NCT00173004

    Angiotensinogen Gene and Hypertension

    National Taiwan University Hospital 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00173030

    Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein Genes

    National Taiwan University Hospital 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00180024

    Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

    Not yet reported Technische Universität Dresden Est. completion 2005-09 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00184587

    Prophylactic Treatment of Episodic Cluster Headache

    Not yet reported Norwegian University of Science and Technology 40 participants Est. completion 2009-12 1 site
    Other conditions: Cluster Headache
    View official trial listing →
  • Completed NCT NCT00185055

    The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

    Not yet reported Daiichi Sankyo 20 participants Est. completion 2005-02
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00185068

    An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

    Not yet reported Daiichi Sankyo 110 participants Est. completion 2004-10 16 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185120

    Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

    Not yet reported Daiichi Sankyo 152 participants Est. completion 2006-09 20 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00190580

    Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

    Not yet reported KVT-Study Group 312 participants Est. completion 2008-04 1 site Stand-alone
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00192803

    Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs

    Not yet reported Rambam Health Care Campus 20 participants 1 site
    Other conditions: NIDDM
    View official trial listing →
  • Status unknown NCT NCT00198562

    Hypertension Control Based on Home Blood Pressure

    Not yet reported Ministry of Health, Labour and Welfare, Japan 2600 participants Est. completion 2012-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00199927

    Statins in Proteinuric Nephropathies

    Not yet reported Mario Negri Institute for Pharmacological Research 217 participants Est. completion 2008-03 16 sites
    Other conditions: Chronic Nephropathy, Proteinuria, Hypertension
    View official trial listing →
  • Status unknown NCT NCT00202618

    Rationale and Design for Shiga Microalbuminuria Reduction Trial

    Not yet reported Shiga University 160 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension, Diabetes Mellitus, Albuminuria
    View official trial listing →
  • Completed NCT NCT00208767

    Effect of Valsartan on Carotid Artery Disease

    Not yet reported Emory University 120 participants Est. completion 2009-11 1 site
    Other conditions: Carotid Artery Diseases, Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT00210275

    Ontario Printed Educational Materials (PEMs) for Physician Behaviour Change

    Not yet reported Institute for Clinical Evaluative Sciences 5000 participants Est. completion 2016-07 Stand-alone
    Type 2 diabetes Other conditions: Education, Medical, Continuing, Practice Patterns, Hypertension
    View official trial listing →
  • Completed NCT NCT00212901

    High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy

    Not yet reported Ottawa Hospital Research Institute 30 participants Est. completion 2006-09 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00221533

    Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients

    University Hospital, Ghent 250 participants Est. completion 2006-08 1 site
    Other conditions: Vascular Diseases, Arterial Stiffness
    View official trial listing →
  • Completed NCT NCT00221845

    Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients

    Not yet reported Heidelberg University 400 participants Est. completion 2010-01 33 sites Stand-alone
    Other conditions: Children, Chronic Renal Failure, Hypertension, Acquired Kidney Disease, Congenital Kidney Disease
    View official trial listing →
  • Completed NCT NCT00224549

    PHARES Study: Management of Resistant Hypertension

    Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2009-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00224809

    Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation

    Not yet reported Baylor Research Institute 250 participants Est. completion 2007-05 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Coronary Disease
    View official trial listing →
  • Status unknown NCT NCT00225667

    Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

    Not yet reported Connolly, Stuart, M.D. 200 participants Est. completion 2007-07 1 site
    Other conditions: Atrial Fibrillation, Hypertension
    View official trial listing →
  • Completed NCT NCT00232882

    Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

    Not yet reported Institut de Recherches Cliniques de Montreal 86 participants Est. completion 2006-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00235287

    Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease

    Not yet reported Herlev Hospital 60 participants 1 site
    Cardiovascular disease Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00237588

    Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

    Not yet reported Ullevaal University Hospital 25 participants Est. completion 2005-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00240019

    Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.

    Not yet reported Stanford University 30 participants Est. completion 2006-04 2 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00241904

    Reducing Total Cardiovascular Risk in an Urban Community

    Not yet reported Johns Hopkins University 525 participants Est. completion 2010-05 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Coronary Disease, Diabetes Mellitus, Atherosclerosis, Cerebral Arteriosclerosis, Hypertension
    View official trial listing →
  • Completed NCT NCT00246584

    A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

    Not yet reported Novartis 300 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00248807

    A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.

    Not yet reported VA Office of Research and Development 30 participants Est. completion 2012-04 1 site
    Other conditions: Orthostatic Hypotension, Spinal Cord Injuries
    View official trial listing →
  • Completed NCT NCT00249795

    Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)

    Not yet reported Sanofi 9016 participants Est. completion 2009-08 30 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00250562

    A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

    Not yet reported Novartis 1171 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00252317

    Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis

    Not yet reported Copenhagen University Hospital, Rigshospitalet 64 participants Est. completion 2008-10 1 site
    Other conditions: Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT00254475

    A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

    Not yet reported Novartis 871 participants Est. completion 2006-09 2 sites
    Other conditions: Essential Hypertension, Hypercholesterolemia
    View official trial listing →
  • Withdrawn NCT NCT00256035

    Interleukin-4 (IL-4) as a Marker of Atherosclerosis

    Not yet reported Melbourne Health
    Other conditions: Atherosclerosis, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00263393

    Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)

    Not yet reported The George Institute 3712 participants Est. completion 2009-06 1 site
    Cardiovascular disease Other conditions: Angina Pectoris, Cerebrovascular Accidents, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00264641

    The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study

    Not yet reported Hypoglycaemia Research Group 20 participants Est. completion 2008-02 1 site
    Other conditions: Hypoglycemia, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT00275639

    The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant

    Not yet reported Mayo Clinic 62 participants Est. completion 2007-08 1 site
    Other conditions: Liver Transplant Recipients
    View official trial listing →
  • Withdrawn NCT NCT00280215

    Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

    Not yet reported Mayo Clinic Est. completion 2011-12
    Other conditions: Hyperoxaluria
    View official trial listing →
  • Completed NCT NCT00283686

    HALT Progression of Polycystic Kidney Disease Study A

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 558 participants Est. completion 2014-06 7 sites
    Other conditions: Kidney, Polycystic
    View official trial listing →
  • Completed NCT NCT00292162

    Curing Atrial Fibrillation in Heart Failure

    Not yet reported NHS Greater Glasgow and Clyde 41 participants Est. completion 2009-07 1 site
    Heart failure Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT00294775

    Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis

    Not yet reported Odense University Hospital 140 participants Est. completion 2009-06 1 site
    Other conditions: Aortic Valve Stenosis, Left Ventricular Hypertrophy, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00295542

    Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

    Not yet reported University of Vigo 3344 participants Est. completion 2009-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00309257

    Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

    Not yet reported Mario Negri Institute for Pharmacological Research 9 participants Est. completion 2009-10 1 site
    Other conditions: Alport Syndrome
    View official trial listing →
  • Completed NCT NCT00310778

    Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker

    Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2007-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00316576

    Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)

    University Hospital, Caen 160 participants Est. completion 2006-11 1 site
    Other conditions: Kidney Failure, Acute, Critical Illness
    View official trial listing →
  • Completed NCT NCT00317252

    Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization

    Not yet reported Hamilton Health Sciences Corporation 220 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Kidney Failure
    View official trial listing →
  • Terminated NCT NCT00318474

    Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

    Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 184 participants Est. completion 2010-03 1 site
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Terminated NCT NCT00319202

    Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects

    Not yet reported Fundación Cardiovascular de Colombia 56 participants Est. completion 2012-02 1 site
    Other conditions: Glucose Intolerance, Obesity
    View official trial listing →
  • Completed NCT NCT00320879

    Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria

    Not yet reported Steno Diabetes Center Copenhagen 52 participants Est. completion 2004-11 1 site
    Type 2 diabetes Other conditions: Microalbuminuria
    View official trial listing →
  • Completed NCT NCT00320970

    Angiotensin II Antagonism of TGF-Beta 1

    Not yet reported Providence Health & Services 36 participants Est. completion 2004-09 1 site
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00321945

    A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers

    Emory University 546 participants Est. completion 2009-10 3 sites
    Other conditions: Atrial Fibrillation, Atrial Flutter
    View official trial listing →
  • Completed NCT NCT00323258

    Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease

    Not yet reported Duke University 143 participants Est. completion 2011-03 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00325806

    Ramipril - Hypertension

    Not yet reported Sanofi 1008 participants Est. completion 2005-08
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00340678

    Renoprotection in Early Diabetic Nephropathy in Pima Indians

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 170 participants Est. completion 2014-03 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00344513

    Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)

    Not yet reported GlaxoSmithKline 50000 participants Est. completion 2005-06-30
    Heart failure
    View official trial listing →
  • Completed NCT NCT00347087

    Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

    Not yet reported Charite University, Berlin, Germany 36 participants Est. completion 2007-06 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00355589

    Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

    Not yet reported Pfizer Est. completion 2007-03 60 sites
    Other conditions: Hypertension, Blood Pressure, High
    View official trial listing →
  • Completed NCT NCT00360178

    Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

    Not yet reported Novartis 198 participants Est. completion 2006-12 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00361023

    Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

    Not yet reported Shanghai Jiao Tong University School of Medicine 25 participants Est. completion 2006-07
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT00361127

    Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart Failure

    Not yet reported Piergiuseppe Agostoni 100 participants Est. completion 2013-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00367562

    Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

    Not yet reported Hospital Britanico 20 participants Est. completion 2005-12 1 site
    Other conditions: IGA Nephropathy
    View official trial listing →
  • Suspended NCT NCT00369538

    Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

    Not yet reported University Hospital, Strasbourg, France 20 participants 1 site
    Other conditions: Proteinuria, Hypertension, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00376272

    GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

    Not yet reported Gruppo di Ricerca GISSI 1442 participants Est. completion 2008-03 114 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT00382863

    Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) Trial

    Not yet reported, Not yet reported Paracor Medical, Inc 220 participants Est. completion 2012-05 35 sites
    Heart failure
    View official trial listing →
  • Terminated NCT NCT00388388

    Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

    Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 1 participants Est. completion 2009-12 1 site
    Prediabetes Other conditions: Pre-hypertension
    View official trial listing →
  • Completed NCT NCT00389168

    Irbesartan and Atenolol in Hypertensive Heart Disease

    Not yet reported, Not yet reported Karolinska Institutet 115 participants Est. completion 1997-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00395005

    Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease Patients

    National Taiwan University Hospital 50 participants Est. completion 2006-10
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00396721

    Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

    Not yet reported Josep m Cruzado 23 participants Est. completion 2010-02 1 site
    Other conditions: Glomerulonephritis, IGA, Nephropathy, IGA, IGA Nephropathy
    View official trial listing →
  • Completed NCT NCT00400582

    A Pharmacogenomic Study of Candesartan in Heart Failure

    Not yet reported Montreal Heart Institute 300 participants Est. completion 2010-04 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00403481

    An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

    Not yet reported Daiichi Sankyo 192 participants Est. completion 2007-12 27 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00407680

    Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

    Not yet reported Kitasato University 80 participants Est. completion 2009-03 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00412932

    An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

    Not yet reported Daiichi Sankyo 178 participants Est. completion 2008-04 29 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00417222

    Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan

    Not yet reported Tohoku University 1145 participants Est. completion 2013-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00421733

    The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

    Not yet reported Abbott 281 participants Est. completion 2009-06 72 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00429364

    Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

    Not yet reported Carelon Research 608 participants Est. completion 2014-02 26 sites
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00430638

    A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

    Not yet reported Daiichi Sankyo 278 participants Est. completion 2007-10 29 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00430924

    Inhibition of Aldosterone in Patients With Chronic Renal Disease

    Not yet reported Lene Boesby 42 participants Est. completion 2009-08 2 sites
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00437463

    Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

    Not yet reported Sanofi 60 participants Est. completion 2010-09 1 site
    Other conditions: Glomerulonephritis
    View official trial listing →
  • Status unknown NCT NCT00437775

    ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects

    Assaf-Harofeh Medical Center 300 participants Est. completion 2007-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Suspended NCT NCT00438412

    Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea

    Regional Hospital Holstebro 40 participants 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00438503

    Glucose in Dialysis Water in Diabetics With Chronic Renal Failure

    Not yet reported Regional Hospital Holstebro 18 participants Est. completion 2007-05 1 site
    Other conditions: Renal Failure, Chronic, Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT00446862

    The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

    University of Alabama at Birmingham 36 participants Est. completion 2012-12 6 sites
    Other conditions: Fabry Disease, Proteinuria
    View official trial listing →
  • Completed NCT NCT00454662

    Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

    Not yet reported COLM Study Research Organization 5141 participants Est. completion 2011-09 1 site
    Cardiovascular disease Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Terminated NCT NCT00456963

    Prevention of Diabetes and Hypertension

    Not yet reported Istituto Auxologico Italiano 3000 participants Est. completion 2010-03 1 site
    Other conditions: Diabetes Mellitus, Hypertension
    View official trial listing →
  • Completed NCT NCT00457483

    Nijmegen Antihypertensive Management Improvement Study

    Not yet reported Radboud University Medical Center 120 participants Est. completion 2011-03 1 site
    Other conditions: Primary Hypertension
    View official trial listing →
  • Completed NCT NCT00459771

    Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

    Not yet reported The Netherlands Cancer Institute 210 participants Est. completion 2014-12 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00471562

    Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors

    Not yet reported Wake Forest University Health Sciences 18 participants Est. completion 2009-10 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00485368

    Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome

    Not yet reported Bayside Health 17 participants Est. completion 2006-09
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00486187

    Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

    Not yet reported Dr. Milan Gupta 103 participants Est. completion 2009-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00490958

    Telmisartan in Haemodialysis Patients With Chronic Heart Failure

    Not yet reported University of Campania Luigi Vanvitelli 351 participants Est. completion 2005-06 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00492128

    Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

    Not yet reported Yokohama City University Medical Center 196 participants Est. completion 2010-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00498368

    Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy

    Not yet reported Mayo Clinic 34 participants Est. completion 2015-09 5 sites
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Terminated NCT NCT00498433

    Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

    Not yet reported Novartis 46 participants Est. completion 2012-03 2 sites
    Other conditions: Hypertension, Abdominal Obesity
    View official trial listing →
  • Completed NCT NCT00498472

    NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial

    Not yet reported Università degli Studi di Brescia 330 participants Est. completion 2010-04 1 site
    Heart failure
    View official trial listing →
  • Terminated NCT NCT00512369

    Effects of PA-1 Transcriptional Regulation on Monocyte Function

    Vanderbilt University 125 participants Est. completion 2011-07 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT00517582

    Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

    Not yet reported Vanderbilt University 13 participants Est. completion 2015-12 1 site
    Other conditions: Angioneurotic Edema
    View official trial listing →
  • Completed NCT NCT00519870

    Losartan Therapy in Pulmonary Hypertension

    Not yet reported Baskent University Est. completion 2005-07
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT00522925

    A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension

    Not yet reported Ligand Pharmaceuticals 280 participants Est. completion 2008-05 15 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00523744

    Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

    Not yet reported Novartis 257 participants Est. completion 2007-12 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00527514

    Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

    Not yet reported Daiichi Sankyo 185 participants Est. completion 2008-04 18 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00528385

    Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System

    Not yet reported Medical University of Gdansk
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00529750

    Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension

    Not yet reported Sanofi 108 participants Est. completion 2005-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00530595

    Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

    Not yet reported Saitama Medical University
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00541268

    Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality

    Not yet reported Danish Study Group 1116 participants Est. completion 2016-07 4 sites
    Heart failure Other conditions: Dilated Cardiomyopathy, Reduced LVEF
    View official trial listing →
  • Status unknown NCT NCT00541853

    CCB Safety Study in Treatment of Hypertension of ADPKD

    Not yet reported Kyorin University 150 participants Est. completion 2012-11 6 sites
    Other conditions: Kidney, Polycystic, Autosomal Dominant
    View official trial listing →
  • Terminated NCT NCT00555217

    VA NEPHRON-D: Diabetes iN Nephropathy Study

    Not yet reported US Department of Veterans Affairs 1448 participants Est. completion 2014-10 31 sites Stand-alone
    Type 2 diabetes Other conditions: Kidney Disease, Nephropathy
    View official trial listing →
  • Terminated NCT NCT00559286

    Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels

    Not yet reported RWTH Aachen University 40 participants Est. completion 2009-01 1 site
    Type 2 diabetes Other conditions: Arterial Hypertension
    View official trial listing →
  • Status unknown NCT NCT00561327

    PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites

    German Heart Institute 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00561704

    Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

    Not yet reported Shanghai Jiao Tong University School of Medicine 80 participants Est. completion 2007-10
    Type 2 diabetesChronic kidney disease Other conditions: Obese, Glucose Metabolism, Angiotensin II Type 1 Receptor Blockers
    View official trial listing →
  • Completed NCT NCT00566774

    A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies

    Not yet reported Brigham and Women's Hospital 5860 participants Est. completion 2010-11 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00572312

    Optimalization of Nephroprotection Using Atorvastatin (Sortis)

    Not yet reported Medical University of Gdansk
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00572663

    Optimalization of Nephroprotection Using N-Acetylcysteine

    Not yet reported Medical University of Gdansk
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Terminated NCT NCT00582114

    Hypertension in Hemodialysis Patients (Aim 3)

    Not yet reported Indiana University 200 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Hemodialysis, Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT00587470

    Angiotensin-II Blockade in Mitral Regurgitation

    Not yet reported Mayo Clinic 60 participants Est. completion 2001-08 1 site
    Other conditions: Mitral Regurgitation
    View official trial listing →
  • Completed NCT NCT00589732

    Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent

    Not yet reported Seung-Jung Park 220 participants Est. completion 2009-12 5 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00605072

    The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial

    Not yet reported University of Southern California 53 participants Est. completion 2012-12 2 sites Stand-alone
    Other conditions: Cognitive Impairment, Hypertension, Aging
    View official trial listing →
  • Completed NCT NCT00607672

    The RAS, Fibrinolysis and Cardiopulmonary Bypass

    Not yet reported Vanderbilt University 111 participants Est. completion 2011-12 2 sites
    Cardiovascular disease Other conditions: Angiotensin Converting Enzyme, Angiotensin Receptor Blockers, Cardiopulmonary Bypass, Fibrinolysis, Inflammation
    View official trial listing →
  • Terminated NCT NCT00613964

    The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure

    Not yet reported Nara Medical University 200 participants Est. completion 2013-05 1 site
    Heart failure Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT00617877

    Antihypertensive Response to Losartan and Genetic Polymorphisms

    Not yet reported Merck Sharp & Dohme LLC 800 participants Est. completion 2009-06
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00630708

    Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency

    Not yet reported Nanfang Hospital, Southern Medical University 309 participants Est. completion 2014-03 1 site
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Terminated NCT NCT00638131

    Bosentan Use in Patients With Diabetic Nephropathy

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 1 participants Est. completion 2010-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00663377

    Effects of Losartan on Insulin Resistance in Patients With Heart Failure

    Not yet reported Tottori University Hospital 16 participants Est. completion 2007-03
    Heart failure
    View official trial listing →
  • Completed NCT NCT00666536

    The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

    Not yet reported Novartis 728 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00668408

    LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure

    Not yet reported Azienda Ospedaliero-Universitaria Careggi 1000 participants Est. completion 2012-10 66 sites
    Heart failure Other conditions: Lung Diseases, Obstructive, Chronic Hypoxemia
    View official trial listing →
  • Completed NCT NCT00670787

    Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

    Not yet reported Kyushu University 207 participants Est. completion 2011-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00672451

    Rhubarb and Angiotensin Converting Enzyme Inhibitor

    Not yet reported Wake Forest University 8 participants Est. completion 2009-05 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00674596

    The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria

    Not yet reported Gulhane School of Medicine 60 participants Est. completion 2008-03 1 site
    Other conditions: Diabetes, Proteinuria, Renin Angiotensin System
    View official trial listing →
  • Completed NCT NCT00675662

    Trim Tots Pre-school Obesity Prevention Programme

    Not yet reported Institute of Child Health 173 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT00679237

    Risk Reduction in Coronary Heart Disease

    Not yet reported Sorlandet Hospital HF 1600 participants Est. completion 2019-12 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00681226

    Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

    Not yet reported Bayside Health 200 participants Est. completion 2012-01 1 site
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT00685945

    Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3

    Not yet reported Vanderbilt University 24 participants Est. completion 2009-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00690586

    Fluid Balance, Hormones and Urine Proteomics in Nephrotic Syndrome in Childhood

    Aarhus University Hospital 21 participants Est. completion 2010-05 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT00696384

    A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

    Not yet reported Takeda 418 participants Est. completion 2009-04 45 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00701428

    Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment

    Not yet reported Skaraborg Hospital 90 participants Est. completion 2014-02 1 site
    Other conditions: Hypertension, Sleep Apnea
    View official trial listing →
  • Completed NCT NCT00701649

    Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension

    Not yet reported Cytos Biotechnology AG 60 participants Est. completion 2009-11 6 sites
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00702221

    Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension

    Not yet reported BTG International Inc. 20 participants Est. completion 2010-09 12 sites Stand-alone
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00710372

    Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

    Not yet reported Cytos Biotechnology AG 83 participants Est. completion 2010-11 1 site
    Other conditions: Mild Essential Hypertension, Moderate Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT00711789

    Angiotensin in Septic Kidney Injury Trial

    Not yet reported Austin Health 12 participants 2 sites
    Other conditions: Acute Renal Failure, Sepsis, Septic Shock
    View official trial listing →
  • Completed NCT NCT00720226

    Efficacy of Losartan in Preventing Progression of COPD

    Not yet reported Johns Hopkins University 106 participants Est. completion 2016-08 1 site
    Other conditions: COPD, Emphysema, Chronic Bronchitis, Smoking
    View official trial listing →
  • Completed NCT NCT00721773

    Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients

    Not yet reported Sun Yat-sen University 200 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Renal Function Disorder
    View official trial listing →
  • Terminated NCT NCT00729365

    PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)

    Not yet reported Northwestern University 65 participants Est. completion 2010-06 6 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00732069

    Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

    Not yet reported Vanderbilt University 19 participants Est. completion 2011-12 1 site
    Other conditions: End Stage Renal Failure on Dialysis, Complication of Hemodialysis
    View official trial listing →
  • Status unknown NCT NCT00734123

    Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

    Not yet reported Hospital Arnau de Vilanova 2948 participants Est. completion 2013-05 1 site
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT00736294

    Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 198 participants Est. completion 2015-03 8 sites
    Other conditions: Atrial Fibrillation, Atrial Flutter
    View official trial listing →
  • Completed NCT NCT00741156

    The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution

    Not yet reported The Hospital for Sick Children 12 participants Est. completion 2010-01 1 site
    Other conditions: Hypertension, Congestive Cardiomyopathy
    View official trial listing →
  • Status unknown NCT NCT00742066

    Role of AT1-receptor Blockers in Insulin-induced Vasodilation.

    Not yet reported Maastricht University Medical Center 32 participants Est. completion 2009-07 1 site
    Other conditions: Hypertension, Insulin Resistance, Microcirculation
    View official trial listing →
  • Completed NCT NCT00742274

    A European Study on Medical Management Versus TAG Device + Medical Management for Acute Uncomplicated Type B Dissection

    Not yet reported W.L.Gore & Associates 61 participants Est. completion 2013-10
    Other conditions: Aortic Diseases
    View official trial listing →
  • Withdrawn NCT NCT00745953

    Regression of Fatty Heart by Valsartan Therapy

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2009-08 1 site
    Metabolic syndrome Other conditions: Lipotoxicity
    View official trial listing →
  • Completed NCT NCT00750308

    Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

    Not yet reported Vanderbilt University 27 participants Est. completion 2009-05
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT00757250

    Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

    Not yet reported US Biotest, Inc. 13 participants Est. completion 2011-12 3 sites Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Terminated NCT NCT00763893

    Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome

    Not yet reported Assistance Publique - Hôpitaux de Paris 303 participants Est. completion 2014-12 1 site
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00771810

    Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

    Not yet reported Tarix Pharmaceuticals 34 participants Est. completion 2011-12 6 sites
    Other conditions: Thrombocytopenia, Neutropenia, Lymphopenia, Anemia
    View official trial listing →
  • Completed NCT NCT00774904

    Adiponectin and Insulin Resistance in Diabetic Nephropathy

    Not yet reported Xi'an Jiaotong University 80 participants Est. completion 2007-11 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00775840

    Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.

    Not yet reported Takeda 22 participants Est. completion 2008-12 37 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT00791830

    Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan

    Not yet reported University of Aarhus 82 participants Est. completion 2013-01 6 sites
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00796744

    Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers

    Not yet reported US Biotest, Inc. 78 participants Est. completion 2011-05 12 sites
    Other conditions: Foot Ulcer, Diabetic, Diabetic Foot
    View official trial listing →
  • Terminated NCT NCT00806585

    Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)

    Not yet reported Merck Sharp & Dohme LLC 620 participants Est. completion 2010-06
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00819845

    Ramipril Versus Carvedilol in Duchenne and Becker Patients

    Not yet reported Catholic University, Italy 194 participants Est. completion 2016-12 1 site
    Other conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT00834600

    Renin Profiling in Selection of Initial Antihypertensive Drug

    Not yet reported The Louis & Rachel Rudin Foundation 185 participants Est. completion 2011-10 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00848250

    Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children

    Not yet reported Vanderbilt University Medical Center 21 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Congenital Heart Disease
    View official trial listing →
  • Completed NCT NCT00853658

    Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

    Not yet reported Novartis Pharmaceuticals 7064 participants Est. completion 2015-10 806 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT00853827

    Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

    Not yet reported Novartis Pharmaceuticals 613 participants Est. completion 2013-01 129 sites
    Cardiovascular disease Other conditions: Coronary Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT00854763

    Olmesartan on Ambulatory Blood Pressure Change

    National Taiwan University Hospital 100 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00857285

    Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

    Not yet reported Daiichi Sankyo 130 participants Est. completion 2003-09 3 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT00858299

    The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria

    Not yet reported Samsung Medical Center 500 participants Est. completion 2011-12 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00863252

    Mycophenolate Mofetil for IgA Nephropathy

    Not yet reported The University of Hong Kong 40 participants Est. completion 2009-03 1 site
    Other conditions: IGA Nephropathy
    View official trial listing →
  • Terminated NCT NCT00863980

    Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

    Not yet reported Kyoto Prefectural University of Medicine 1500 participants Est. completion 2013-07 32 sites
    Cardiovascular disease Other conditions: Angina Pectoris, Myocardial Ischemia, Acute Coronary Syndrome, Hypertension
    View official trial listing →
  • Completed NCT NCT00865449

    Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis

    Not yet reported Instituto Nacional de Cardiologia Ignacio Chavez 20 participants Est. completion 2012-03 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00866879

    Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

    Not yet reported Northwestern University 275 participants Est. completion 2019-03 1 site Stand-alone
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT00874432

    Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease

    Not yet reported University of Wisconsin, Madison 43 participants Est. completion 2011-12 1 site
    Cardiovascular diseaseChronic kidney disease
    View official trial listing →
  • Terminated NCT NCT00878969

    Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

    Not yet reported Vanderbilt University 78 participants Est. completion 2015-06 1 site
    Other conditions: Oxidative Stress, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT00886353

    Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

    Not yet reported Apeiron Biologics 22 participants Est. completion 2009-12 1 site
    Cardiovascular disease Other conditions: Pulmonary Diseases, Kidney Diseases, Cancer Diseases
    View official trial listing →
  • Status unknown NCT NCT00890279

    Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)

    Not yet reported Ministry of Health, Labour and Welfare, Japan 160 participants Est. completion 2012-11 9 sites
    Other conditions: Kidney, Polycystic, Autosomal Dominant
    View official trial listing →
  • Completed NCT NCT00890591

    Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

    Not yet reported Daiichi Sankyo 144 participants Est. completion 2007-08
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00893425

    Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

    Not yet reported Gulhane School of Medicine 78 participants Est. completion 2009-04 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00894387

    Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure

    Not yet reported Novartis Pharmaceuticals 1639 participants Est. completion 2012-08 308 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT00901719

    Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation

    Not yet reported University of Edinburgh 12 participants Est. completion 2010-05 1 site Stand-alone
    Heart failure Other conditions: Heart Disease, Vasodilatation
    View official trial listing →
  • Completed NCT NCT00901745

    Interaction of Apelin and Angiotensin in the Human Forearm Circulation

    Not yet reported University of Edinburgh 12 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Heart Disease, Vasodilation
    View official trial listing →
  • Completed NCT NCT00901888

    Interaction of Apelin and Angiotensin in the Human Forearm Circulation

    Not yet reported University of Edinburgh 12 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Heart Disease, Vasodilation
    View official trial listing →
  • Completed NCT NCT00907374

    Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria

    Not yet reported Charles Drew University of Medicine and Science 46 participants Est. completion 2009-04 1 site
    Other conditions: Microalbuminuria
    View official trial listing →
  • Terminated NCT NCT00913393

    Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy

    Not yet reported Kyntra Bio 46 participants Est. completion 2010-06 28 sites
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT00914524

    Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy

    Not yet reported Daiichi Sankyo Co., Ltd. 49 participants Est. completion 2006-10 1 site
    Chronic kidney disease Other conditions: Chronic Glomerulonephritis
    View official trial listing →
  • Terminated NCT NCT00915928

    Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors

    Not yet reported Odense University Hospital 47 participants Est. completion 2012-06
    Other conditions: Hematoma, Subdural, Chronic
    View official trial listing →
  • Completed NCT NCT00920764

    A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

    Not yet reported AbbVie (prior sponsor, Abbott) 92 participants Est. completion 2010-05 28 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00921570

    The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension

    Not yet reported Gulhane School of Medicine 105 participants Est. completion 2009-05 1 site
    Other conditions: Diabetes, Hypertension, Proteinuria
    View official trial listing →
  • Completed NCT NCT00922311

    Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade

    Not yet reported The University of Hong Kong 25 participants Est. completion 2010-12 2 sites
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT00923156

    Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure

    Not yet reported Novartis Pharmaceuticals 123 participants Est. completion 2011-02 16 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT00926341

    The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

    Not yet reported Aligarh Muslim University 110 participants Est. completion 2008-09 1 site
    Metabolic syndrome
    View official trial listing →
  • Withdrawn NCT NCT00930995

    Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C

    Not yet reported Kaiser Permanente 2 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00933231

    Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

    Not yet reported Astellas Pharma Inc 281 participants Est. completion 2018-04-03 13 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00933920

    Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate Hypertension

    Not yet reported Novartis Pharmaceuticals 124 participants 5 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00939588

    Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

    Not yet reported Novartis Pharmaceuticals 88 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00949351

    Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy

    Not yet reported Lerdsin General Hospital 80 participants Est. completion 2010-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00961207

    Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients

    Not yet reported Cook County Health 2 participants Est. completion 2012-09 1 site
    Chronic kidney disease Other conditions: Microalbuminuria, Diabetes, Proteinuria, Albuminuria
    View official trial listing →
  • Completed NCT NCT00962949

    The Renin-Aldosterone Axis in Postural Tachycardia Syndrome

    Not yet reported Vanderbilt University Medical Center 28 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Postural Orthostatic Tachycardia Syndrome (POTS)
    View official trial listing →
  • Terminated NCT NCT00968383

    Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment

    Not yet reported National Institute of Cardiology, Warsaw, Poland 11 participants Est. completion 2012-12 1 site Stand-alone
    Cardiovascular diseaseHeart failure Other conditions: Heart Diseases
    View official trial listing →
  • Completed NCT NCT00971165

    Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension

    Not yet reported Hospital de Clinicas de Porto Alegre 655 participants Est. completion 2014-09 2 sites
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00985322

    Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis

    Not yet reported Mario Negri Institute for Pharmacological Research 269 participants Est. completion 2016-04 29 sites
    Other conditions: Left Ventricular Hypertrophy, Hypertension
    View official trial listing →
  • Completed NCT NCT00990639

    Effect of Candesartan in Alcoholic Liver Fibrosis

    Not yet reported, Not yet reported Yonsei University 85 participants Est. completion 2009-03 1 site
    Other conditions: Alcoholic Liver Disease
    View official trial listing →
  • Withdrawn NCT NCT00994253

    Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics

    Not yet reported Corewell Health East Est. completion 2012-12 1 site
    Other conditions: Hypertension, Diabetes Type 2
    View official trial listing →
  • Withdrawn NCT NCT01009944

    Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study

    Not yet reported Brigham and Women's Hospital Est. completion 2019-03-19 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01011062

    Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes

    Not yet reported Institute for Clinical and Experimental Medicine 23 participants Est. completion 2009-08 1 site
    Type 2 diabetes Other conditions: Insulin Resistance
    View official trial listing →
  • Status unknown NCT NCT01011660

    Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 13542 participants Est. completion 2012-12 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01014338

    Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Imperial College London 80 participants Est. completion 2012-09 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01015937

    Effect of Turmeric on Diabetic Nephropathy

    Not yet reported Shaheed Faghihi Hospital 50 participants Est. completion 2009-08 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Status unknown NCT NCT01016886

    Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research

    Not yet reported, Not yet reported University of Alberta 99 participants Est. completion 2016-09 1 site
    Heart failure Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01024543

    Role of Angiotensin II in Insulin-induced Microvascular Activity

    Not yet reported Maastricht University Medical Center 18 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Insulin Sensitivity, Microcirculation
    View official trial listing →
  • Completed NCT NCT01028534

    Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)

    Not yet reported Kyoto University, Graduate School of Medicine 150 participants Est. completion 2013-12 2 sites
    Obstructive sleep apnea Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01036659

    Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema

    Not yet reported Bernstein, Jonathan A., M.D. 50 participants Est. completion 2013-12 3 sites
    Other conditions: Angioedema
    View official trial listing →
  • Completed NCT NCT01037530

    Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants

    Not yet reported Hull University Teaching Hospitals NHS Trust 33 participants Est. completion 2012-12 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT01049646

    Interaction of Apelin and Angiotensin in the Systemic Circulation

    Not yet reported University of Edinburgh 12 participants Est. completion 2010-04 1 site
    Other conditions: Renin Angiotensin System
    View official trial listing →
  • Completed NCT NCT01053026

    Evaluation of Effects of Exercise Training and ARB in DM Patients

    National Taiwan University Hospital 15 participants Est. completion 2011-12 1 site
    Other conditions: Vascular Function, Exercise Training
    View official trial listing →
  • Completed NCT NCT01062451

    An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence

    Not yet reported Baylor College of Medicine 80 participants Est. completion 2013-11-20 1 site
    Other conditions: Methamphetamine Dependence, Methamphetamine Abuse, Substance Abuse
    View official trial listing →
  • Completed NCT NCT01066572

    Paramedic Initiated Lisinopril For Acute Stroke Treatment

    Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 14 participants Est. completion 2011-12 4 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01068418

    Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity

    Not yet reported Brigham and Women's Hospital 26 participants Est. completion 2011-09 1 site
    Other conditions: Obesity, Vitamin D Deficiency, Hypertension
    View official trial listing →
  • Completed NCT NCT01069549

    Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes

    Post Graduate Institute of Medical Education and Research, Chandigarh 476 participants Est. completion 2011-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01071642

    The Influence of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Patients Undergoing Non-emergent Coronary Angiography

    Not yet reported Soroka University Medical Center 100 participants Est. completion 2010-11 1 site
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT01071681

    Survey to Assess Why People Are Not Responding to Treatment in Hypertension

    Bayer 1589 participants Est. completion 2010-09 1 site
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01078363

    Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy

    Not yet reported Stanford University 96 participants Est. completion 2015-04 2 sites
    Other conditions: Cardiac Allograft Vasculopathy
    View official trial listing →
  • Completed NCT NCT01078584

    Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients

    Abbott 7993 participants Est. completion 2011-09 568 sites
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01089452

    Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study

    Not yet reported Monash University 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01091961

    Study of Preoperative Management of Angiotensin Converting Enzyme Inhibitor (ACEi) and Angiotensin Receptor Blocker (ARB) Medications

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 200 participants Est. completion 2011-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01092130

    Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure

    Not yet reported University Medical Center Groningen 101 participants Est. completion 2012-09 1 site
    Heart failure
    View official trial listing →
  • Terminated NCT NCT01096121

    Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children

    Not yet reported Assistance Publique - Hôpitaux de Paris 5 participants Est. completion 2012-06 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Terminated NCT NCT01101269

    Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease

    Not yet reported University of Virginia 6 participants Est. completion 2014-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01101503

    The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes

    Not yet reported Xiang Guang-da 1000 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT01113047

    Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

    Not yet reported Novartis 347 participants 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01115426

    Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

    Not yet reported University Magna Graecia 20 participants Est. completion 2008-01 1 site
    Other conditions: IGA Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT01116180

    Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System

    Not yet reported Louise Faerch 9 participants Est. completion 2013-02 1 site
    Other conditions: Type 1 Diabetes, Hypoglycemia
    View official trial listing →
  • Status unknown NCT NCT01118494

    Study of Urinary Angiotensinogen as a Marker to Warn the Deterioration of Renal Function in CKD Patients Early.

    Fudan University 400 participants Est. completion 2011-06 1 site
    Chronic kidney disease Other conditions: Urinary Angiotensinogen
    View official trial listing →
  • Completed NCT NCT01118520

    AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)

    Not yet reported Imperial College London 224 participants Est. completion 2015-04 9 sites
    Other conditions: Abdominal Aortic Aneurysm
    View official trial listing →
  • Terminated NCT NCT01121120

    Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients

    Not yet reported Tarix Pharmaceuticals 75 participants Est. completion 2020-12 10 sites
    Other conditions: Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT01124656

    Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes

    Not yet reported Takeda 26 participants Est. completion 2007-05
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01129557

    Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

    Not yet reported Columbia University 46 participants Est. completion 2012-12 1 site
    Chronic kidney disease Other conditions: Proteinuric Kidney Disease, Hypertensive Nephrosclerosis, IgA Nephropathy, Focal Segmental Glomerulosclerosis, Glomerulopathy (Obesity-associated), Glomerulonephritis, Membranous
    View official trial listing →
  • Terminated NCT NCT01132768

    The Confirmatory Olmesartan Plaque Regression Study

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 114 participants Est. completion 2011-06 1 site
    Other conditions: Essential Hypertension, Carotid Plaque
    View official trial listing →
  • Completed NCT NCT01137474

    A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker

    Not yet reported AstraZeneca 2996 participants Est. completion 2013-02 329 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01150201

    Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease

    Not yet reported The University of Hong Kong 80 participants Est. completion 2014-08 1 site
    Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT01150461

    Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2010-07 1 site
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01152567

    Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

    AstraZeneca 50000 participants Est. completion 2010-11 56 sites
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01154361

    AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study

    Not yet reported Technical University of Munich 1 site
    Other conditions: Angioedema
    View official trial listing →
  • Withdrawn NCT NCT01154504

    The Role of Adrenomedullin on the Outcome of Severe Heart Failure: a Clinical Randomized Study

    Not yet reported Federal University of São Paulo Est. completion 2012-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT01162980

    The Angiotensin Converting Enzyme (ACE) Inhibitor SwitchBack Study

    McGill University Health Centre/Research Institute of the McGill University Health Centre 100 participants Est. completion 2012-07 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01166165

    Effect of Vitamin D Replacement During Winter Months in Patients With Hypertension

    Not yet reported Regional Hospital Holstebro 136 participants Est. completion 2011-04 1 site
    Other conditions: Hypertension, Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT01167920

    Virtual Hypertension Clinic

    Not yet reported The Cleveland Clinic 74 participants Est. completion 2014-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01173029

    Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

    Universidade Gama Filho 92 participants Est. completion 2010-12 1 site
    Cardiovascular disease Other conditions: Systemic Arterial Hypertension, Hypertension Resistant to Conventional Therapy
    View official trial listing →
  • Status unknown NCT NCT01184599

    A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy

    Not yet reported Kagawa University 30 participants 4 sites
    Other conditions: Glomerulonephritis, IGA, Hypertension
    View official trial listing →
  • Completed NCT NCT01188304

    A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 44 participants Est. completion 2010-10 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01188317

    A Study of Aleglitazar in Combination With Ibuprofen in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 44 participants Est. completion 2011-09 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01193101

    Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 389 participants Est. completion 2011-04 34 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01195662

    A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication

    Not yet reported AstraZeneca 2245 participants Est. completion 2013-02 298 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01195818

    Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 53 participants Est. completion 2014-09 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT01198275

    n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation

    Not yet reported Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 199 participants Est. completion 2008-05 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT01202721

    Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)

    Not yet reported Hamilton Health Sciences Corporation 85 participants Est. completion 2016-11 13 sites
    Other conditions: Cardiac Disease
    View official trial listing →
  • Completed NCT NCT01210430

    Local Vasoconstriction in Postural Tachycardia Syndrome

    Not yet reported New York Medical College 74 participants Est. completion 2015-06 1 site
    Other conditions: Postural Tachycardia Syndrome
    View official trial listing →
  • Completed NCT NCT01225445

    Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

    Not yet reported Chinese University of Hong Kong 60 participants Est. completion 2010-10 1 site
    Other conditions: Biopsy-confirmed IgA Nephropathy, Proteinuria Less Than 0.5 g Per Day, Normal Blood Pressure, Serum Creatinine Below 120 Umol/l
    View official trial listing →
  • Terminated NCT NCT01233635

    Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)

    Not yet reported University of Pittsburgh 228 participants Est. completion 2007-11 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01237028

    Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers

    Not yet reported Yonsei University 168 participants Est. completion 2016-08 7 sites
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT01241383

    Effect of Bosentan in Scleroderma Renal Crisis

    Not yet reported Assistance Publique - Hôpitaux de Paris 16 participants Est. completion 2016-06 1 site
    Other conditions: Scleroderma Renal Crisis
    View official trial listing →
  • Completed NCT NCT01252368

    Human Intestinal Amino Acid Absorption and the Role of a Local (Renin)-Angiotensin System (RAS)

    University of Zurich 48 participants Est. completion 2011-05 1 site
    Other conditions: Healthy Participants, Hypertension
    View official trial listing →
  • Completed NCT NCT01256411

    A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 341 participants Est. completion 2012-04 33 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01258764

    Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril

    Not yet reported Scripps Translational Science Institute 2 participants Est. completion 2014-03 1 site
    Other conditions: Hypertension, Grade 1, Hypertension Treatment, N of 1 Study Design, Hypertension
    View official trial listing →
  • Completed NCT NCT01281306

    An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

    Not yet reported Novartis Pharmaceuticals 910 participants Est. completion 2011-12 90 sites
    Other conditions: Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT01281787

    PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer

    Not yet reported European Institute of Oncology 320 participants Est. completion 2013-10 1 site
    Other conditions: Lung Cancer, Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT01292694

    Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure

    Not yet reported Vanderbilt University 12 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Hypertension, Pure Autonomic Failure, Multiple System Atrophy
    View official trial listing →
  • Terminated NCT NCT01300611

    TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation

    Not yet reported Tarix Pharmaceuticals 20 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Myelofibrosis, Acute Lymphoblastic Leukemia, Chronic Myelocytic Leukemia, Non Hodgkins Lymphoma, Hodgkins Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Status unknown NCT NCT01305850

    The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients

    Not yet reported Chulalongkorn University 100 participants Est. completion 2011-10 1 site
    Other conditions: Peritoneal Membrane Failure
    View official trial listing →
  • Status unknown NCT NCT01310920

    The Role of Angiotensinogen Gene Polymorphism in the Pathogenesis of Non-familial Sick Sinus Syndrome

    China Medical University Hospital 400 participants 1 site
    Other conditions: Sick Sinus Syndrome
    View official trial listing →
  • Completed NCT NCT01312714

    Vitamin D3 Supplementation in Dialysis Patients

    Not yet reported Regional Hospital Holstebro 64 participants Est. completion 2012-09 1 site
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01320722

    Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function

    Not yet reported Brigham and Women's Hospital 242 participants Est. completion 2015-06 1 site
    Other conditions: Renal Function, Endothelial Function, Blood Pressure, Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT01324245

    Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

    Not yet reported Georgetown University 45 participants Est. completion 2006-05 1 site
    Other conditions: Salt-sensitive Hypertension
    View official trial listing →
  • Completed NCT NCT01328769

    Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)

    Not yet reported Paul N. Hopkins 49 participants Est. completion 2014-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01340326

    The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling

    Not yet reported Dong-A University 800 participants Est. completion 2014-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01343823

    Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema

    Not yet reported Shire 79 participants Est. completion 2012-06-01 39 sites
    Other conditions: ACE Inhibitor Induced Angioedema
    View official trial listing →
  • Completed NCT NCT01356849

    Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

    Not yet reported AbbVie (prior sponsor, Abbott) 149 participants Est. completion 2012-08 72 sites
    Chronic kidney disease
    View official trial listing →
  • Terminated NCT NCT01362036

    Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia

    Not yet reported Tarix Pharmaceuticals 2 participants Est. completion 2012-04 1 site
    Other conditions: Myelodysplastic Syndrome (MDS)
    View official trial listing →
  • Completed NCT NCT01371747

    Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)

    Not yet reported Relypsa, Inc. 324 participants Est. completion 2013-06 43 sites
    Chronic kidney disease Other conditions: Hypertension, Hyperkalemia
    View official trial listing →
  • Status unknown NCT NCT01377285

    Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

    Not yet reported National Taiwan University Hospital 350 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Completed NCT NCT01380717

    Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)

    Not yet reported University of Aarhus 83 participants Est. completion 2014-02 1 site
    Other conditions: Chronic Kidney Insufficiency, Hypertension, Vasodilation
    View official trial listing →
  • Terminated NCT NCT01390181

    The Effect of Losartan in Bicuspid Aortic Valve Patients

    Not yet reported University of Michigan 4 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Bicuspid Aortic Valve, Thoracic Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT01393782

    Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study

    Not yet reported George Washington University 20 participants Est. completion 2014-01 1 site
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT01396395

    Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina

    Not yet reported Merck KGaA, Darmstadt, Germany 402 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Stable Angina, Coronary Disease
    View official trial listing →
  • Completed NCT NCT01398267

    A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril

    Not yet reported Hoffmann-La Roche 55 participants Est. completion 2012-10 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01407237

    Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV

    Massachusetts General Hospital 30 participants 1 site
    Other conditions: HIV-infection
    View official trial listing →
  • Completed NCT NCT01407627

    Evaluation of Fructose Ingestion and the Renin Angiotensin System in Humans

    Not yet reported University of Calgary 64 participants Est. completion 2021-05 1 site
    Chronic kidney disease
    View official trial listing →
  • Terminated NCT NCT01409993

    Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis

    Not yet reported Vanderbilt University 78 participants Est. completion 2016-11 1 site
    Prediabetes
    View official trial listing →
  • Completed NCT NCT01411371

    Catheter Ablation Versus Medical Treatment of AF in Heart Failure

    Not yet reported Barts & The London NHS Trust 50 participants Est. completion 2013-02 1 site
    Heart failure Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01413542

    Pharmacogenetics of Ace Inhibitor-Associated Angioedema

    Not yet reported Vanderbilt University 44 participants Est. completion 2014-07 1 site
    Other conditions: Hypertension, Diabetes Type 2
    View official trial listing →
  • Completed NCT NCT01425411

    Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

    Not yet reported Mustafa Kemal University 38 participants Est. completion 2008-11 1 site
    Other conditions: Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Active, not recruiting NCT NCT01426529

    Caveolin-1 and Vascular Dysfunction

    Not yet reported Brigham and Women's Hospital 120 participants Est. completion 2026-10-15 1 site Stand-alone
    Other conditions: Hypertension, Insulin Resistance
    View official trial listing →
  • Withdrawn NCT NCT01426724

    Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease

    Not yet reported University of Virginia Est. completion 2013-08 1 site
    Chronic kidney disease Other conditions: Secondary Hyperparathyroidism
    View official trial listing →
  • Withdrawn NCT NCT01432106

    The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

    Not yet reported University of Michigan Est. completion 2012-12 1 site
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01437371

    Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?

    Not yet reported University Hospital, Clermont-Ferrand 35 participants Est. completion 2014-06 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT01444833

    Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker

    Not yet reported Slovak Academy of Sciences 35 participants Est. completion 2012-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01447654

    Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy

    Not yet reported Henning Bundgaard 130 participants Est. completion 2014-06 1 site
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01454583

    Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany

    Stiftung Institut fuer Herzinfarktforschung 15337 participants Est. completion 2012-07
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Terminated NCT NCT01456208

    Genetic Mechanisms in Human Hypertension

    Brigham and Women's Hospital 150 participants Est. completion 2020-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01459042

    Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

    Shanghai Jiao Tong University School of Medicine 2000 participants 1 site
    Other conditions: Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT01461499

    Shiga Microalbuminuria Reduction Trial-2

    Not yet reported Shiga University 237 participants Est. completion 2014-12 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01465126

    Enalapril in Collagen Type 4 Nephropathy

    University of Sao Paulo 19 participants Est. completion 2011-10
    Other conditions: Collagen Type-4 Nephropathies
    View official trial listing →
  • Status unknown NCT NCT01471860

    BAROSTIM NEO System in the Treatment of Heart Failure

    Not yet reported CVRx, Inc. 94 participants Est. completion 2021-08-11 30 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT01483781

    A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus

    Not yet reported Janssen Research & Development, LLC 36 participants Est. completion 2012-08 1 site
    Type 2 diabetes Other conditions: Plasma Volume
    View official trial listing →
  • Completed NCT NCT01485900

    Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment

    Not yet reported Sanofi 20 participants Est. completion 2012-08 2 sites
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT01500590

    Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria

    Not yet reported Hospital Authority, Hong Kong 1400 participants Est. completion 2019-08 1 site Stand-alone
    Other conditions: Diabetes, Hypertensive Disease
    View official trial listing →
  • Completed NCT NCT01502787

    Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients

    Not yet reported University of Texas Southwestern Medical Center 46 participants Est. completion 2013-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01508468

    Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

    Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2016-08-31 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Status unknown NCT NCT01508663

    The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease

    Not yet reported Yonsei University 1600 participants 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01511042

    Vascular Dysfunction in Diabetes: Genes and Hormones

    Brigham and Women's Hospital 100 participants Est. completion 2020-06 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01511263

    Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 86 participants Est. completion 2016-07 1 site
    Other conditions: Primary Amyloidosis of Light Chain Type
    View official trial listing →
  • Completed NCT NCT01525888

    Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy

    Not yet reported Soroka University Medical Center 100 participants Est. completion 2013-12 Stand-alone
    Other conditions: Radiographic Contrast Agent Nephropathy
    View official trial listing →
  • Completed NCT NCT01541267

    The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria

    Not yet reported Medical University of Gdansk 20 participants Est. completion 2011-11
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT01543971

    Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs)

    Not yet reported Tarix Pharmaceuticals 18 participants Est. completion 2010-03 1 site
    Other conditions: Miscellaneous Peripheral Blood Cell Abnormalities
    View official trial listing →
  • Completed NCT NCT01545479

    Increased Renal Oxygenation and Angiotensin Converting Enzyme Inhibition

    Not yet reported Instituto de Cardiologia do Rio Grande do Sul 5 participants Est. completion 2010-12
    Other conditions: Renal Disease
    View official trial listing →
  • Completed NCT NCT01552954

    Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan

    Not yet reported Seoul National University Bundang Hospital 269 participants Est. completion 2013-10 7 sites
    Chronic kidney disease Other conditions: Hypertension, Microalbuminuria
    View official trial listing →
  • Completed NCT NCT01553539

    Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

    Not yet reported Wake Forest University Health Sciences 20 participants Est. completion 2013-01 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Bone Cancer, Clear Cell Sarcoma of the Kidney, Ovarian Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Uterine Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage III Uterine Sarcoma, Stage IV Adult Soft Tissue Sarcoma, Stage IV Uterine Sarcoma
    View official trial listing →
  • Withdrawn NCT NCT01554254

    Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

    Not yet reported Tarix Pharmaceuticals 1 site
    Other conditions: Cord Blood Transplant, Hematologic Malignancy, Inherited Metabolic Disease
    View official trial listing →
  • Completed NCT NCT01557140

    A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy

    Not yet reported Federal University of Minas Gerais 42 participants Est. completion 2006-12 1 site Stand-alone
    Heart failure Other conditions: Chagas Cardiomyopathy, Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01563731

    Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives

    Not yet reported Istituto Auxologico Italiano 200 participants Est. completion 2021-03-31 1 site
    Cardiovascular disease Other conditions: Transient Ischemic Attack, Hypertension
    View official trial listing →
  • Completed NCT NCT01575652

    Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients

    Not yet reported Turkish Nephrology Association 43 participants Est. completion 2009-01
    Other conditions: Disorders Associated With Peritoneal Dialysis
    View official trial listing →
  • Completed NCT NCT01581476

    Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

    Not yet reported University of Cambridge 443 participants Est. completion 2017-06 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01588795

    Renal Denervation in Diabetic Nephropathy

    Not yet reported Assistance Publique - Hôpitaux de Paris 25 participants Est. completion 2016-01 1 site
    Chronic kidney disease Other conditions: Persistent Proteinuria With Type II Diabetes
    View official trial listing →
  • Status unknown NCT NCT01589380

    A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)

    Not yet reported Seoul National University Hospital 100 participants Est. completion 2014-12 7 sites
    Other conditions: Critical Stenosis of Aortic Valve
    View official trial listing →
  • Completed NCT NCT01609959

    New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering

    Not yet reported Nara Medical University 70 participants Est. completion 2013-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01613118

    Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

    Not yet reported Travere Therapeutics, Inc. 109 participants Est. completion 2024-03-25 33 sites
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT01615198

    Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 588 participants Est. completion 2013-07 79 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT01624064

    Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology

    Not yet reported, Not yet reported Ministry of Health, Sri Lanka 200 participants Est. completion 2013-10 1 site
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT01635192

    Effects of Probiotic VSL#3 on Expression of Small Intestinal Renin-angiotensin System

    Not yet reported Göteborg University 24 participants Est. completion 2013-07 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT01646671

    Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients

    Not yet reported Novartis Pharmaceuticals 35 participants Est. completion 2013-02 9 sites Stand-alone
    Other conditions: Severe Hypertension
    View official trial listing →
  • Status unknown NCT NCT01665235

    Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis

    Not yet reported RenJi Hospital 200 participants Est. completion 2014-08 1 site
    Other conditions: Blood Pressure Variability, Intracranial Artery Stenosis
    View official trial listing →
  • Completed NCT NCT01669434

    Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

    Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site Stand-alone
    Other conditions: Hypotension on Induction
    View official trial listing →
  • Completed NCT NCT01669928

    Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control

    Not yet reported Imperial College London 103 participants Est. completion 2015-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01670903

    The Effect of Angiotensin II Type 1 Receptor Antagonists on the Size and Expansion Rate of Abdominal Aortas in Hypertensive Patients

    Sheba Medical Center 150 participants 2 sites
    Other conditions: Aneurysm, Hypertension
    View official trial listing →
  • Completed NCT NCT01675362

    Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?

    Not yet reported Mansoura University 160 participants Est. completion 2014-10 1 site
    Other conditions: Kidney Calculi
    View official trial listing →
  • Completed NCT NCT01679132

    BAROSTIM NEO Hypertension Pivotal Trial

    Not yet reported CVRx, Inc. 10 participants Est. completion 2025-07-23 11 sites Stand-alone
    Other conditions: Uncontrolled Hypertension
    View official trial listing →
  • Completed NCT NCT01682577

    Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

    Not yet reported Dexa Medica Group 18 participants Est. completion 2008-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01684748

    Angiotensin II Blockade and Inflammation in Obesity

    Not yet reported Virginia Polytechnic Institute and State University 20 participants Est. completion 2011-08
    Other conditions: Overweight, Obese, Prehypertension, Hypertension
    View official trial listing →
  • Completed NCT NCT01691118

    A Trial of Fimasartan for Early Diastolic Heart Failure

    Not yet reported Asan Medical Center 60 participants Est. completion 2015-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01691781

    The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study

    Not yet reported Brigham and Women's Hospital 41 participants Est. completion 2016-12 1 site
    Other conditions: Hyperparathyroidism
    View official trial listing →
  • Completed NCT NCT01692795

    Cardiovascular Medication Use Before First Myocardial Infarction

    London School of Hygiene and Tropical Medicine 17000 participants Est. completion 2013-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT01702688

    Evaluation of Lysine-Specific Demethylase 1

    Not yet reported Brigham and Women's Hospital 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01713270

    Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 200 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Hypertension, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01713920

    Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM

    Not yet reported Sang Hyun Ihm, MD PhD 68 participants Est. completion 2014-09 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01716819

    Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity

    Not yet reported Central Hospital, Nancy, France 101 participants Est. completion 2015-03 1 site
    Other conditions: Obesity, Abdominal
    View official trial listing →
  • Completed NCT NCT01734096

    Renal Response to Lower Body Negative Pressure in Pre-hypertensive States

    Not yet reported PD Dr. Grégoire Wuerzner 78 participants Est. completion 2016-04 2 sites
    Other conditions: Hypertension, Obesity, White Coat Hypertension, Resistant Hypertension
    View official trial listing →
  • Status unknown NCT NCT01737138

    Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2018-04 1 site
    Chronic kidney disease
    View official trial listing →
  • Terminated NCT NCT01752985

    Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

    Not yet reported Bristol-Myers Squibb 319 participants Est. completion 2015-06-30 62 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01771783

    RAS-Peptide-Profile Study in Healthy Male Subjects

    Not yet reported University Hospital, Basel, Switzerland 12 participants 1 site Stand-alone
    Other conditions: RAS Peptide Profile in Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT01790906

    Renal Sympathetic Denervation for Patients With Chronic Heart Failure

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 200 participants Est. completion 2017-04 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01792518

    MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

    Not yet reported Boehringer Ingelheim 360 participants Est. completion 2015-12 74 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01805453

    Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma

    Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2017-05-15 1 site
    Other conditions: Newly-diagnosed Glioblastoma
    View official trial listing →
  • Completed NCT NCT01808196

    Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

    Not yet reported Children's Hospital Medical Center, Cincinnati 6 participants Est. completion 2015-02-13 1 site
    Other conditions: Eosinophilic Esophagitis, Connective Tissue Disorders
    View official trial listing →
  • Completed NCT NCT01821053

    Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus

    Odense University Hospital 85 participants Est. completion 2015-10 1 site
    Other conditions: Preeclampsia, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01827202

    RAS Quantification in Patients With Aliskiren or Candesartan

    Not yet reported Medical University of Vienna 24 participants Est. completion 2016-02 1 site
    Chronic kidney disease Other conditions: Hypertension, Proteinuria
    View official trial listing →
  • Completed NCT NCT01828138

    Hypertension and Urine Protease Activity in Preeclampsia

    Not yet reported Odense University Hospital 35 participants Est. completion 2015-10 1 site
    Other conditions: Preeclampsia, Hypertension, Proteinuria, Pregnancy
    View official trial listing →
  • Status unknown NCT NCT01829126

    Development and Prevention of Severe Heart Disease in Systemic Sclerosis

    Gabriele Valentini 765 participants Est. completion 2016-08 11 sites
    Heart failure Other conditions: Systemic Sclerosis, Cardiac Diseases, Heart Block, Cardiac Arrhythmia
    View official trial listing →
  • Completed NCT NCT01830530

    HIGH Altitude CArdiovascular REsearch in the ANDES

    Not yet reported Istituto Auxologico Italiano 100 participants Est. completion 2012-10 1 site
    Other conditions: Hypertension, High Altitude
    View official trial listing →
  • Withdrawn NCT NCT01831037

    The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

    University of Arkansas Est. completion 2019-12 4 sites
    Other conditions: Chronic Hepatitis C, Chronic Hepatitis B
    View official trial listing →
  • Terminated NCT NCT01837069

    Risk Factor Control Before Orthopedic Surgery

    Not yet reported NYU Langone Health 198 participants Est. completion 2018-04-02 1 site
    OsteoarthritisCardiovascular disease
    View official trial listing →
  • Completed NCT NCT01840072

    China Antihypertensive Trial in Acute Ischemic Stroke

    Not yet reported Tulane University 4071 participants Est. completion 2016-05 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01847313

    The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease

    Not yet reported Karl Neff 20 participants Est. completion 2015-11 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01850160

    Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension

    Not yet reported Farma de Colombia SA 124 participants Est. completion 2015-05 8 sites
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01856361

    Ramipril for the Treatment of Oligospermia

    Not yet reported Weill Medical College of Cornell University 2 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Oligospermia, Teratospermia, Asthenozoospermia, Male Infertility
    View official trial listing →
  • Completed NCT NCT01857999

    Losartan in Decompensated Heart Failure

    Not yet reported InCor Heart Institute 21 participants Est. completion 2011-03 1 site
    Heart failure Other conditions: Low Cardiac Output
    View official trial listing →
  • Terminated NCT NCT01867047

    ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

    Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site
    Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
    View official trial listing →
  • Withdrawn NCT NCT01882374

    Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation

    Not yet reported Tarix Pharmaceuticals Est. completion 2013-12 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Withdrawn NCT NCT01882387

    Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

    Not yet reported Tarix Pharmaceuticals Est. completion 2013-12 2 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01885559

    HALT Progression of Polycystic Kidney Disease Study B

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 486 participants Est. completion 2014-06 7 sites
    Other conditions: Kidney, Polycystic
    View official trial listing →
  • Completed NCT NCT01891513

    ACE Inhibitors Combined With Exercise for Seniors - Pilot Study

    University of Florida 104 participants Est. completion 2017-06 1 site
    Other conditions: Hypertension, Aging
    View official trial listing →
  • Status unknown NCT NCT01893788

    Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy

    Not yet reported Nagoya University 100 participants 1 site
    Other conditions: Hypertensive Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT01904695

    Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study

    Not yet reported China Academy of Chinese Medical Sciences 192 participants Est. completion 2015-12 1 site
    Other conditions: Primary Hypertension, Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT01904981

    Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial)

    Not yet reported Yonsei University 19 participants Est. completion 2017-04-18 1 site Stand-alone
    Other conditions: Small Abdominal Aortic Aneurysm
    View official trial listing →
  • Terminated NCT NCT01906307

    A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome

    Not yet reported La Jolla Pharmaceutical Company 6 participants Est. completion 2015-12 1 site
    Other conditions: Hepatorenal Syndrome Type I and Type II
    View official trial listing →
  • Completed NCT NCT01919801

    Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema

    Not yet reported Shire 118 participants Est. completion 2015-08-22 55 sites
    Other conditions: Angiotensin Converting Enzyme Inhibitor Induced Angioedema
    View official trial listing →
  • Completed NCT NCT01920815

    Bicuspid Valve Aortopathy Feasibility Study

    Oregon Health and Science University 500 participants Est. completion 2017-10-04 6 sites
    Other conditions: Bicuspid Aortic Valve
    View official trial listing →
  • Completed NCT NCT01923597

    Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.

    Not yet reported University of Campinas, Brazil 50 participants Est. completion 2015-03 1 site
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01932450

    Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control

    Not yet reported Mei changlin 100 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Autosomal Dominant Polycystic Kidney Disease, Hypertension
    View official trial listing →
  • Completed NCT NCT01936012

    Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition

    Not yet reported Dexa Medica Group 34 participants Est. completion 2013-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01938664

    A Pilot Study of Candesartan as a Treatment for Cocaine Dependence

    Not yet reported Baylor College of Medicine 30 participants Est. completion 2016-07 1 site
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Withdrawn NCT NCT01948232

    Pilot Study of Perindopril in Childhood Cancer Survivors

    Not yet reported The Hospital for Sick Children Est. completion 2015-07 1 site Stand-alone
    Other conditions: Childhood Cancer Survivors
    View official trial listing →
  • Completed NCT NCT01963507

    Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme

    Not yet reported Federal University of São Paulo 136 participants Est. completion 2013-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01964079

    Comparision of Blood Pressure Variability Between Amlodipine and Losartan

    Not yet reported Wonju Severance Christian Hospital 144 participants Est. completion 2017-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01974544

    Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines

    Not yet reported Pontificia Universidad Catolica de Chile 150 participants Est. completion 2016-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01982695

    Cardiomyopathy in DMD: Lisinopril vs. Losartan

    Not yet reported Nationwide Children's Hospital 23 participants Est. completion 2013-09 6 sites
    Other conditions: Duchenne Muscular Dystrophy (DMD), Cardiomyopathy
    View official trial listing →
  • Terminated NCT NCT01983462

    Vascular Dysfunction in Human Obesity Hypertension

    Not yet reported Gary L. Pierce 33 participants Est. completion 2020-06 1 site
    Other conditions: Obesity, Prehypertension, Hypertension
    View official trial listing →
  • Status unknown NCT NCT01992796

    Angiotensin II Antagonist in Severe Sepsis

    Not yet reported University of Salerno 300 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Severe Sepsis
    View official trial listing →
  • Completed NCT NCT01996085

    Non-invasive Haemodynamic Assessment in Hypertension

    Not yet reported Military Institute od Medicine National Research Institute 144 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Terminated NCT NCT02007720

    Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF

    Not yet reported Novartis Pharmaceuticals 876 participants Est. completion 2017-06-16 132 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02008110

    Carbohydrate Antigen 125-guided Therapy in Heart Failure

    Not yet reported Fundación para la Investigación del Hospital Clínico de Valencia 360 participants Est. completion 2015-05 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Terminated NCT NCT02008786

    Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD

    Not yet reported Cardiology Research UBC 18 participants Est. completion 2019-09-13 1 site
    Other conditions: Coronary Artery Dissection, Spontaneous
    View official trial listing →
  • Status unknown NCT NCT02010905

    Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120 participants Est. completion 2018-01 6 sites
    Other conditions: Tetralogy of Fallot, Heart Defects, Congenital, Ventricular Dysfunction, Right
    View official trial listing →
  • Completed NCT NCT02034435

    Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism

    Not yet reported Vanderbilt University Medical Center 44 participants Est. completion 2019-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02040441

    Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

    Not yet reported, Not yet reported Peter Rossing 1777 participants Est. completion 2018-11 15 sites
    Chronic kidney disease Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT02046395

    Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

    Not yet reported Tulane University School of Medicine 28 participants Est. completion 2019-12 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02054390

    Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction

    Ankara University 459 participants Est. completion 2014-06 1 site
    Metabolic syndromeCardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02064868

    Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients

    Not yet reported Novartis Pharmaceuticals 2666 participants Est. completion 2017-04-25 357 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02086019

    Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes

    Not yet reported Brighton and Sussex University Hospitals NHS Trust 250 participants Est. completion 2019-12-12 1 site
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT02096406

    Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass

    Not yet reported University of Alberta 126 participants Est. completion 2018-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02129725

    Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

    Not yet reported Vanderbilt University Medical Center 15 participants Est. completion 2016-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02130687

    Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

    Not yet reported Vanderbilt University 106 participants Est. completion 2020-08 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02133872

    Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients

    Not yet reported University of Florida 34 participants Est. completion 2018-11-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02133885

    Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients

    Not yet reported, Not yet reported University of Florida Est. completion 2024-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02145468

    A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

    Not yet reported GlaxoSmithKline 3503 participants Est. completion 2015-12-14 341 sites Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT02170961

    Study of Polymorphisms of RAAS and MMPs in Acute Heart Failure

    University of Monastir 300 participants Est. completion 2016-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT02175355

    Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

    Not yet reported Boehringer Ingelheim 1039 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02184858

    Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension

    Not yet reported University Ghent 13 participants Est. completion 2018-09-17 1 site
    Other conditions: Primary Hypertension, Secondary Hypertension
    View official trial listing →
  • Completed NCT NCT02188121

    Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients

    Not yet reported Mclean Hospital 227 participants Est. completion 2021-10 1 site Stand-alone
    Cardiovascular disease Other conditions: Serious Mental Illness, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Major Depressive Disorder, Psychosis NOS
    View official trial listing →
  • Completed NCT NCT02200822

    Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients

    Not yet reported Hasselt University 80 participants Est. completion 2019-02 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02213224

    Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

    Not yet reported Nanfang Hospital, Southern Medical University 180 participants Est. completion 2017-09 1 site Stand-alone
    MASLD
    View official trial listing →
  • Completed NCT NCT02215733

    The Use of Angiotensin Receptor Blockers and the Risk of Cancer

    Boehringer Ingelheim 1165781 participants
    Other conditions: Neoplasm
    View official trial listing →
  • Completed NCT NCT02220335

    Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure

    Not yet reported Nanjing First Hospital, Nanjing Medical University 98 participants Est. completion 2018-12-30 1 site
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT02226120

    Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction

    Not yet reported Novartis Pharmaceuticals 1980 participants Est. completion 2017-12-28 394 sites Stand-alone
    Heart failure
    View official trial listing →
  • Terminated NCT NCT02240641

    Effect of Caldine® on Renal Function in Balanced Hypertension

    Boehringer Ingelheim 5417 participants
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT02245230

    Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension

    Not yet reported Vanderbilt University 24 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Hypertension, Hypertension, Essential
    View official trial listing →
  • Completed NCT NCT02248896

    Antihypertensive Medications and the Risk of Sepsis

    Boehringer Ingelheim 1129062 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02254252

    Effects of Nicorandil on Angina Symptoms in Patients With Coronary Slow Flow

    Not yet reported Mashhad University of Medical Sciences 54 participants Est. completion 2013-06
    Other conditions: Slow Coronary Flow, Normal, or Near Normal Coronary Angiography, Stable Angina
    View official trial listing →
  • Completed NCT NCT02265861

    Response of VEGF and AT-II to HCG in PCOS

    Not yet reported Nanjing University School of Medicine 60 participants Est. completion 2012-12
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT02294539

    Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients

    Not yet reported Chong-Jin Kim 231 participants Est. completion 2016-05-18 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02298556

    An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes

    Abbott 270 participants Est. completion 2016-03-08 23 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02299388

    To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study

    Not yet reported Tulane University School of Medicine 11 participants Est. completion 2016-12 1 site
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent, Hypertensive Disease
    View official trial listing →
  • Completed NCT NCT02319590

    Anti-Angiotensin-Receptor 1 (ATR1)-, Anti-Endothelin-Receptor A (ETRA)-Antibodies and T Cells in Cardiomyopathy

    Zurich Regional Health Center 80 participants Est. completion 2020-12 1 site
    Other conditions: Cardiac Failure
    View official trial listing →
  • Completed NCT NCT02338843

    A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension

    Not yet reported La Jolla Pharmaceutical Company 344 participants Est. completion 2017-02-18 115 sites Stand-alone
    Other conditions: Catecholamine-resistant Hypotension (CRH), Distributive Shock, High Output Shock, Sepsis
    View official trial listing →
  • Completed NCT NCT02344602

    The Effect of Uric Acid Lowering in Type 1 Diabetes

    Not yet reported University Health Network, Toronto 73 participants Est. completion 2015-09-22 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT02351063

    HF Assessment With BNP in the Home: Part II

    Not yet reported Alere San Diego 1 participants Est. completion 2014-07 13 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT02358096

    A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

    Not yet reported Astellas Pharma Europe B.V. 125 participants Est. completion 2017-03-15 57 sites
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Terminated NCT NCT02358642

    Drug to Prevent Pneumonia in the Tube Fed

    Not yet reported Chinese University of Hong Kong 93 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Pneumonia, Neurological Dysphagia
    View official trial listing →
  • Status unknown NCT NCT02360956

    Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)

    Not yet reported Chinese PLA General Hospital 100 participants Est. completion 2016-06 1 site
    Other conditions: Coronary Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02364089

    Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas

    Not yet reported University Hospital, Bordeaux 78 participants Est. completion 2022-11-23 17 sites
    Other conditions: Adrenal Incidentalomas
    View official trial listing →
  • Completed NCT NCT02373163

    INTERVENCION Trial

    Not yet reported Prevencion 166 participants Est. completion 2016-06-01 1 site
    Other conditions: Blood Pressure, High
    View official trial listing →
  • Completed NCT NCT02377440

    Effects of ACEI on Bone Turnover

    The University of Texas Health Science Center, Houston 32 participants Est. completion 2015-12 2 sites
    Other conditions: Bone Turnover Status in Hypertensive Patients
    View official trial listing →
  • Completed NCT NCT02377661

    Lowering Blood Pressure in Primary Care in Vienna

    Not yet reported Wilhelminenspital Vienna 229 participants Est. completion 2017-05-30 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02378064

    Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation

    Not yet reported CHEOL WHAN LEE, M.D., Ph.D 50 participants Est. completion 2017-12 1 site
    Other conditions: Inflammation Plaque, Atherosclerotic, Coronary Disease, Renin-Angiotensin System
    View official trial listing →
  • Completed NCT NCT02380157

    Blood Pressure Regulation - Role of Potassium

    Not yet reported Glostrup University Hospital, Copenhagen 25 participants Est. completion 2016-12 1 site
    Other conditions: Blood Pressure, Hypertension
    View official trial listing →
  • Status unknown NCT NCT02386293

    Effectiveness of Avapro in Obese Normotensive/Hypertensive African Americans

    Not yet reported Augusta University 30 participants Est. completion 2019-11-30 1 site
    Other conditions: Hypertension, Obesity, Stress, Psychological, Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT02390193

    Effect of Hemodialysis on Upper Airways Collapsibility in Patients With Chronic Kidney Disease

    Not yet reported Centro Universitário de Anapolis 52 participants Est. completion 2020-12-03 1 site Stand-alone
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Status unknown NCT NCT02396901

    Goal Direct Therapy to Prevent Acute Kidney Injury

    Not yet reported University of Sao Paulo 214 participants Est. completion 2017-04 Stand-alone
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Status unknown NCT NCT02403349

    Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol

    Not yet reported Ajou University School of Medicine 105 participants Est. completion 2015-09 Stand-alone
    Cardiovascular disease Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT02409043

    Neuronal and Glial Biomarkers in Stroke

    University of Florida 99 participants Est. completion 2015-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02412761

    Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 42 participants Est. completion 2016-07 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02416024

    Arterial Stiffness and General Anesthesia Induced Hypotension in Patients on Angiotensin-converting Enzyme Inhibitors

    University of Iowa 72 participants Est. completion 2018-09 1 site
    Other conditions: Hypotension, Arterial Stiffness
    View official trial listing →
  • Completed NCT NCT02425969

    A Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values

    Not yet reported Golden Jubilee National Hospital 108 participants Est. completion 2016-10-01 1 site Stand-alone
    Other conditions: Grey-zone Fractional Flow Reserve, Intermediate Coronary Lesions, Stable Angina, Coronary Physiology
    View official trial listing →
  • Completed NCT NCT02431936

    Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress

    Not yet reported Augusta University 50 participants Est. completion 2019-04-16 1 site
    Other conditions: Hypertension, Stress, Psychological, Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT02432339

    Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

    Not yet reported, Not yet reported Augusta University 50 participants Est. completion 2019-11-30 1 site
    Other conditions: Psychological Stress, Hypertension, Renal
    View official trial listing →
  • Completed NCT NCT02432885

    Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial

    Not yet reported InCor Heart Institute 76 participants Est. completion 2013-06
    Other conditions: Myocardial Fibrosis, Muscular Dystrophies
    View official trial listing →
  • Completed NCT NCT02449811

    RAS Peptide Profiles in Patients With Arterial Hypertension

    Insel Gruppe AG, University Hospital Bern 107 participants Est. completion 2018-11 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Suspended NCT NCT02471599

    Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy

    Not yet reported Sun Yat-sen University 100 participants Est. completion 2023-03 1 site Stand-alone
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Status unknown NCT NCT02488252

    Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy

    Not yet reported, Not yet reported The University of Hong Kong 148 participants Est. completion 2021-09 1 site Stand-alone
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Status unknown NCT NCT02499250

    Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients

    Not yet reported Navy General Hospital, Beijing 30 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Refractory Angina Pectoris
    View official trial listing →
  • Status unknown NCT NCT02501772

    The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy

    Not yet reported Mackay Memorial Hospital 60 participants Est. completion 2019-12 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT02513979

    Postoperative Pain and Angiotensin II Receptor Antagonists

    Not yet reported University of Athens 90 participants Est. completion 2018-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02525081

    Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction

    Not yet reported Bispebjerg Hospital 63 participants Est. completion 2016-07 1 site
    Other conditions: Microvascular Angina
    View official trial listing →
  • Status unknown NCT NCT02532777

    The Research of Standard Diagnosis and Treatment for HSPN in Children

    Not yet reported Nanjing Children's Hospital 100 participants Est. completion 2020-07 1 site Stand-alone
    Other conditions: Henoch-Schoenlein Purpura Nephritis
    View official trial listing →
  • Completed NCT NCT02546856

    Safety and Effectiveness of Drug up Titration by Nurses Specialized in Heart Failure (HF) Patients

    Not yet reported Hospital Galdakao-Usansolo 320 participants Est. completion 2019-04-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02585089

    Effects of Cured Pork Peptides on Blood Pressure & Cardiovascular Risk Factors

    Not yet reported Universidad Católica San Antonio de Murcia 50 participants Est. completion 2016-09 1 site
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02587936

    Improving Chronic Disease Management With Pieces

    Not yet reported University of Texas Southwestern Medical Center 18268 participants Est. completion 2022-10-15 4 sites Stand-alone
    Chronic kidney diseaseType 2 diabetes Other conditions: Diabetes, Hypertension, High BP
    View official trial listing →
  • Terminated NCT NCT02591173

    Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure

    Not yet reported Vanderbilt University Medical Center 7 participants Est. completion 2020-07 1 site Stand-alone
    Other conditions: Autonomic Nervous System Disorders, Pure Autonomic Failure, Shy-Drager Syndrome, Orthostatic Hypotension, Dysautonomic
    View official trial listing →
  • Completed NCT NCT02596126

    Secondary Prevention of Cardiovascular Disease in the Elderly Trial

    Not yet reported Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 2499 participants Est. completion 2022-03-31 113 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02597361

    Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)

    Not yet reported Assistance Publique - Hôpitaux de Paris 61 participants Est. completion 2020-02-19 15 sites
    Other conditions: Ehlers-Danlos Syndrome, Vascular Type
    View official trial listing →
  • Completed NCT NCT02605681

    Midkine and ACE-Ang II Induced Endothelial Injury in Sepsis

    Southeast University, China 26 participants Est. completion 2018-06-15 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Terminated NCT NCT02606279

    Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients

    Not yet reported Wake Forest University Health Sciences 1 participants Est. completion 2016-08-04 1 site
    Other conditions: HIV, Aging, Sarcopenia, Angiotensin Receptor Antagonists
    View official trial listing →
  • Terminated NCT NCT02620384

    Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.

    Not yet reported Aultman Health Foundation 147 participants Est. completion 2017-12-29 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02623036

    The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

    Not yet reported Memorial Health University Medical Center 20 participants Est. completion 2018-04 1 site
    Other conditions: Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT02624050

    Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs

    Not yet reported Milton S. Hershey Medical Center 51 participants Est. completion 2018-01-31 1 site
    Other conditions: Hypotension, Anesthesia
    View official trial listing →
  • Status unknown NCT NCT02627209

    The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis

    Not yet reported Ozlem Sahin 280 participants Est. completion 2017-01 1 site
    Other conditions: Sarcoidosis, Tuberculosis
    View official trial listing →
  • Completed NCT NCT02632747

    Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

    Not yet reported Boehringer Ingelheim 31 participants Est. completion 2019-07-02 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1, Obesity
    View official trial listing →
  • Completed NCT NCT02639637

    Effect of DPP4 Inhibition on Vasoconstriction

    Not yet reported Vanderbilt University 18 participants Est. completion 2017-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02646397

    Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension

    Not yet reported Shanghai Changzheng Hospital 508 participants Est. completion 2017-12 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Withdrawn NCT NCT02649998

    Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF

    Not yet reported Chinese University of Hong Kong Est. completion 2022-06 1 site
    Other conditions: Heart Decompensation
    View official trial listing →
  • Status unknown NCT NCT02660866

    Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

    Not yet reported North Texas Veterans Healthcare System 200 participants Est. completion 2019-07 12 sites
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT02661217

    Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

    Not yet reported Novartis Pharmaceuticals 1002 participants Est. completion 2018-06-20 152 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT02678000

    Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function

    Not yet reported Novartis Pharmaceuticals 84 participants Est. completion 2018-10-11 12 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02709018

    A Controlled Trial of Losartan in Posttraumatic Stress Disorder

    Not yet reported University of California, San Diego 149 participants Est. completion 2020-09-29 6 sites Stand-alone
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Status unknown NCT NCT02721342

    Remission Clinic in Proteinuric Chronic Nephropathies

    Mario Negri Institute for Pharmacological Research 1500 participants Est. completion 2022-11 13 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02729441

    Perindopril vs Ramipril for Persistence in MAU Reduction Study

    Not yet reported Sunnybrook Health Sciences Centre 23 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Diabetes, Microalbuminuria
    View official trial listing →
  • Completed NCT NCT02744456

    N-of-1 Trials for Blood Pressure Medications in Adults

    Not yet reported Columbia University 10 participants Est. completion 2017-12-31 1 site
    Other conditions: Hypertension, High Blood Pressure
    View official trial listing →
  • Completed NCT NCT02759367

    Increasing Potassium Intake in Hypertensive Individuals

    Not yet reported Samuel Lunenfeld Research Institute, Mount Sinai Hospital 20 participants Est. completion 2015-06
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02774460

    The Precision Hypertension Care Study

    Not yet reported Uppsala University 280 participants Est. completion 2021-06-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT02787798

    Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure

    Not yet reported University Hospital, Toulouse 4 participants Est. completion 2018-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Terminated NCT NCT02788656

    Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)

    Not yet reported Brigham and Women's Hospital 4 participants Est. completion 2018-11-09 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02796170

    Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes

    Not yet reported Tulane University School of Medicine 11 participants Est. completion 2020-08 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02814552

    OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)

    Not yet reported University of Florida 47 participants Est. completion 2018-06-30 3 sites
    Other conditions: High Blood Pressure
    View official trial listing →
  • Completed NCT NCT02816762

    CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea

    Not yet reported Hospital Universitario La Paz 180 participants Est. completion 2020-12 6 sites Stand-alone
    Chronic kidney disease Other conditions: Sleep Apnea
    View official trial listing →
  • Completed NCT NCT02832973

    Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension

    Not yet reported Sao Jose do Rio Preto Medical School 72 participants Est. completion 2018-03 1 site
    Other conditions: Hypertension Resistant to Conventional Therapy
    View official trial listing →
  • Status unknown NCT NCT02847312

    Chronic Cardiovascular and Gut-bacteria Effects of Phenolic Rich Oats in Adults With Above Average Blood Pressure

    Not yet reported University of Reading 30 participants Est. completion 2017-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02857309

    Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure

    Not yet reported Impulse Dynamics 50 participants Est. completion 2018-02-15 8 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02859311

    A Pilot Feasibility Study in Recovered Heart Failure

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 50 participants Est. completion 2018-08 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02874794

    Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

    Not yet reported Novartis Pharmaceuticals 465 participants Est. completion 2019-01-26 81 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02878018

    Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis

    Liaoning University of Traditional Chinese Medicine 600 participants Est. completion 2020-05 1 site
    Other conditions: Henoch-Schonlein Purpura Nephritis
    View official trial listing →
  • Completed NCT NCT02879721

    Expression and Function of the Renin-Angiotensin System in the Esophagus

    Not yet reported Göteborg University 33 participants Est. completion 2012-12 1 site
    Other conditions: Barrett's Esophagus
    View official trial listing →
  • Completed NCT NCT02913664

    Risk Reduction for Alzheimer's Disease

    Not yet reported, Not yet reported University of Texas Southwestern Medical Center 513 participants Est. completion 2022-01-31 4 sites Stand-alone
    Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02929329

    Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

    Not yet reported Cytokinetics 8256 participants Est. completion 2020-09-14 1033 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02944734

    Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

    Not yet reported Shin Poong Pharmaceutical Co. Ltd. 392 participants Est. completion 2015-12 23 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Terminated NCT NCT02959411

    Tolvaptan for Advanced or Refractory Heart Failure

    Not yet reported University of Calgary 9 participants Est. completion 2020-06-30 1 site Stand-alone
    Heart failure Other conditions: Hyponatremia
    View official trial listing →
  • Completed NCT NCT02962778

    RAS Peptide Profiles in Patients With Treatment-resistant Arterial Hypertension

    University Hospital, Basel, Switzerland 20 participants Est. completion 2017-10-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02981212

    Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy

    Not yet reported Yonsei University 100 participants Est. completion 2018-10 1 site
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Withdrawn NCT NCT02985268

    Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF

    Not yet reported Montreal Heart Institute Est. completion 2020-02
    Heart failure Other conditions: Functional Mitral Regurgitation
    View official trial listing →
  • Status unknown NCT NCT03001271

    Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects

    Not yet reported Instituto de Cardiologia do Rio Grande do Sul 32 participants Est. completion 2017-03 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03011775

    Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease

    Not yet reported Ukrainian Medical Stomatological Academy 43 participants Est. completion 2015-09 1 site
    Other conditions: Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance Syndrome
    View official trial listing →
  • Status unknown NCT NCT03015974

    Registry of IgA Nephropathy in Chinese Children

    Peking University First Hospital 1200 participants Est. completion 2024-12 1 site
    Other conditions: IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment
    View official trial listing →
  • Completed NCT NCT03031834

    Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus

    Not yet reported Aristotle University Of Thessaloniki
    Other conditions: Diabetic Autonomic Neuropathy
    View official trial listing →
  • Completed NCT NCT03034265

    New Biomarkers and Difficult-to-treat Hypertension

    Insel Gruppe AG, University Hospital Bern 24 participants Est. completion 2017-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03066804

    A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

    Not yet reported Novartis Pharmaceuticals 2572 participants Est. completion 2019-10-28 380 sites
    Heart failure
    View official trial listing →
  • Suspended NCT NCT03071653

    Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study

    Not yet reported University of Cape Town 30 participants Est. completion 2022-02 1 site
    Other conditions: Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Non-ischemic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT03078101

    EMPRA (EMPagliflozin and RAs in Kidney Disease)

    Not yet reported Medical University of Vienna 51 participants Est. completion 2019-08-07 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03082014

    Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

    Not yet reported Ludwig-Maximilians - University of Munich 101 participants Est. completion 2022-07-28 5 sites
    Other conditions: Cerebral Small Vessel Diseases
    View official trial listing →
  • Terminated NCT NCT03094195

    Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)

    Not yet reported Novartis Pharmaceuticals 130 participants Est. completion 2019-03-07 58 sites
    Other conditions: Post-herpetic Neuralgia
    View official trial listing →
  • Terminated NCT NCT03121092

    ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients

    Not yet reported State University of New York - Downstate Medical Center 188 participants Est. completion 2017-03-07 1 site
    Other conditions: Hypertension, Hypotension
    View official trial listing →
  • Completed NCT NCT03122834

    Effect of Genetic Polymorphism on the Clinical Outcome of Patients With Heart Failure

    Ain Shams University 246 participants Est. completion 2024-06-14 1 site
    Heart failure
    View official trial listing →
  • Active, not recruiting NCT NCT03127631

    A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

    Not yet reported McMaster University 5000 participants Est. completion 2026-12-31 61 sites
    Cardiovascular disease Other conditions: Prostate Cancer
    View official trial listing →
  • Suspended NCT NCT03159988

    Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients

    Not yet reported University of Arizona 6 participants Est. completion 2026-06-01 1 site Stand-alone
    Heart failure Other conditions: Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT03164785

    Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease

    Not yet reported, Not yet reported Second Xiangya Hospital of Central South University 202 participants Est. completion 2022-12-08 1 site
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Terminated NCT NCT03179163

    Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans

    Not yet reported, Not yet reported Penn State University 10 participants Est. completion 2022-12-31 1 site
    Other conditions: Hypertension,Essential
    View official trial listing →
  • Suspended NCT NCT03180450

    The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)

    Not yet reported, Not yet reported Sclnow Biotechnology Co., Ltd. 60 participants Est. completion 2026-12-31 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT03188887

    Treatment of IgA Nephropathy According to Renal Lesions

    Not yet reported Assistance Publique - Hôpitaux de Paris 62 participants Est. completion 2024-01-12 1 site Stand-alone
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT03190304

    The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure

    Not yet reported University of Sao Paulo General Hospital 52 participants Est. completion 2020-09-23 1 site
    Heart failure Other conditions: Exercise Tolerance, Vasodilation, Body Composition, Muscle Strength
    View official trial listing →
  • Status unknown NCT NCT03195023

    Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

    Not yet reported Hospital General Universitario Gregorio Marañon 106 participants Est. completion 2022-12 1 site
    Other conditions: Renal Insufficiency, Chronic, Proteinuria
    View official trial listing →
  • Status unknown NCT NCT03201185

    Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)

    Not yet reported Hospital Clínico Universitario de Valladolid 194 participants Est. completion 2023-08 1 site
    Other conditions: Transcatheter Aortic Valve Replacemen, Angiotensin-Converting Enzyme Inhibitors
    View official trial listing →
  • Terminated NCT NCT03212690

    Study of Renin-angiotensin System in Mechanically Ventilated Subjects

    Not yet reported GlaxoSmithKline 57 participants Est. completion 2019-07-08 2 sites
    Other conditions: Acute Lung Injury
    View official trial listing →
  • Status unknown NCT NCT03216564

    An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes

    Not yet reported Hamad Medical Corporation 320 participants Est. completion 2019-05-10 1 site Stand-alone
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT03217591

    A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

    Not yet reported Akebia Therapeutics 156 participants Est. completion 2019-08-20 54 sites
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT03217825

    Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan

    Not yet reported Windtree Therapeutics 240 participants Est. completion 2018-02-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03219632

    Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG

    Seoul National University Bundang Hospital 72 participants Est. completion 2017-05-30
    Other conditions: Left Ventricular Hypertrophy, Hypertension
    View official trial listing →
  • Terminated NCT NCT03240068

    Angiotensin-(1-7) in Peripheral Arterial Disease

    Not yet reported Milton S. Hershey Medical Center 6 participants Est. completion 2020-03-09 1 site Stand-alone
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT03244514

    Biomarker-guided Implementation of the AKI Bundle

    Not yet reported University Hospital Muenster 280 participants Est. completion 2020-01-26 12 sites Stand-alone
    Other conditions: Acute Kidney Injury (Nontraumatic)
    View official trial listing →
  • Approved For Marketing NCT NCT03245528

    Expanded Access for LJPC-501

    La Jolla Pharmaceutical Company
    Other conditions: Catecholamine Resistant Hypotension (CRH), Distributive Shock, High Output Shock, Sepsis, Vasodilatory Shock
    View official trial listing →
  • Completed NCT NCT03246022

    Characteristics of Obstructive Sleep Apnea Syndrome Related Hypertension and the Effect of Continuous Positive Airway Pressure Treatment on Blood Pressure

    Huai'an No.1 People's Hospital 78 participants Est. completion 2021-12-30 1 site
    Other conditions: Hypertension Secondary
    View official trial listing →
  • Terminated NCT NCT03252093

    Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG

    Not yet reported University of Arizona 6 participants Est. completion 2022-11-15 5 sites Stand-alone
    Other conditions: Coronary Artery Bypass Surgery, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT03255551

    Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure

    Seoul National University Bundang Hospital 50 participants Est. completion 2015-12-31
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03265574

    PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

    Not yet reported South Tees Hospitals NHS Foundation Trust 111 participants Est. completion 2023-08-04 1 site Stand-alone
    Other conditions: Breast Cancer, Non Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT03284099

    Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension

    Not yet reported Chinese University of Hong Kong 4 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension, Non-Dipping
    View official trial listing →
  • Terminated NCT NCT03297294

    Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)

    Not yet reported Novartis Pharmaceuticals 142 participants Est. completion 2019-03-25 64 sites
    Other conditions: Painful Diabetic Neuropathy
    View official trial listing →
  • Suspended NCT NCT03302650

    Angiotensin II for Septic Shock Treatment

    Not yet reported Cairo University 20 participants Est. completion 2019-08-15 1 site Stand-alone
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT03310684

    Pediatric Primary Hypertension and the Renin-Angiotensin System (PHRAS)

    Wake Forest University Health Sciences 35 participants Est. completion 2023-04-26 1 site
    Other conditions: Pediatric Disorder, Pediatric Obesity, Primary Hypertension
    View official trial listing →
  • Withdrawn NCT NCT03315832

    Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study

    Not yet reported, Not yet reported University Hospital, Limoges Est. completion 2025-07-02 1 site Stand-alone
    Other conditions: Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists, Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis Implantation, Hypertrophy, Left Ventricular
    View official trial listing →
  • Completed NCT NCT03317925

    Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)

    Wake Forest University Health Sciences 29 participants Est. completion 2017-04-26 1 site
    Other conditions: Renal Transplant, Renin-Angiotensin System, Rejection Acute Renal, Rejection Chronic Renal, Rejection of Renal Transplant
    View official trial listing →
  • Completed NCT NCT03335904

    AT1R Blockade and Periodic Breathing During Sleep in Hypoxia

    Not yet reported University of British Columbia 14 participants Est. completion 2019-08-01 1 site Stand-alone
    Other conditions: Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder, Chemoreceptor Apnea
    View official trial listing →
  • Completed NCT NCT03354143

    Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

    Not yet reported University of Texas Southwestern Medical Center 85 participants Est. completion 2024-03-30 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03370705

    Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone

    Not yet reported Alfa Wassermann Tunisia 156 participants Est. completion 2020-03-30 3 sites
    Other conditions: Peripheral Arterial Obstructive Disease
    View official trial listing →
  • Completed NCT NCT03371797

    Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial

    PharmEvo Pvt Ltd 800 participants Est. completion 2018-11-05 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT03374449

    Impact of Renin-Angiotensin System Inhibitors Continuation on Outcome After Major Surgery

    Not yet reported Assistance Publique - Hôpitaux de Paris 2222 participants Est. completion 2023-12-24 1 site
    Other conditions: Renin Angiotensin System, Surgery
    View official trial listing →
  • Completed NCT NCT03381716

    Correlation Between Sex and Prognosis of Acute Aortic Dissection in the Chinese Population

    Shenyang Northern Hospital 884 participants Est. completion 2016-05-29
    Other conditions: Acute Aortic Dissection, Sex Role
    View official trial listing →
  • Withdrawn NCT NCT03415906

    Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure

    Not yet reported Hannover Medical School Est. completion 2018-09-06 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Active, not recruiting NCT NCT03417388

    Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

    Not yet reported Cedars-Sinai Medical Center 2476 participants Est. completion 2026-09-14 81 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03418779

    Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD

    Not yet reported, Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: IgA Nephropathy at High Risk of Developing ESRD
    View official trial listing →
  • Status unknown NCT NCT03430284

    Multifactorial Intervention on Diabetes (MIDiab Study)

    Not yet reported Shandong Provincial Hospital 6300 participants Est. completion 2022-12-31 2 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03431077

    A Study of LJPC-501 in Pediatric Patients With Hypotension

    Not yet reported La Jolla Pharmaceutical Company 2 participants Est. completion 2018-04-14 3 sites Stand-alone
    Other conditions: Catecholamine-resistant Hypotension (CRH), Distributive Shock, High Output Shock, Sepsis
    View official trial listing →
  • Status unknown NCT NCT03432468

    Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women

    Not yet reported LanZhou University 102 participants Est. completion 2019-08-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03461003

    N-of-1 Trials In Children With Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 49 participants Est. completion 2021-05-02 1 site Stand-alone
    Other conditions: Pediatric Hypertension
    View official trial listing →
  • Completed NCT NCT03466775

    Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes

    Paris Translational Research Center for Organ Transplantation 1845 participants Est. completion 2017-12-31 2 sites
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Terminated NCT NCT03467217

    Losartan for the Treatment of Pediatric NAFLD

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 83 participants Est. completion 2020-06-30 10 sites
    MASLD
    View official trial listing →
  • Completed NCT NCT03473509

    Primary Care CKD Registry

    Not yet reported University of California, San Francisco 746 participants Est. completion 2015-03 Stand-alone
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03476616

    Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients

    Not yet reported Hippocration General Hospital 198 participants Est. completion 2025-06-30 1 site
    Other conditions: Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT03479554

    China Antihypertensive Trial in Acute Ischemic Stroke II

    Not yet reported Tulane University 4810 participants Est. completion 2023-01-15 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03482440

    Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia

    Not yet reported University of Iowa 24 participants Est. completion 2022-12-31 2 sites
    Other conditions: Preeclampsia
    View official trial listing →
  • Completed NCT NCT03489993

    FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)

    Wake Forest University Health Sciences 8 participants Est. completion 2020-12-23 1 site
    Other conditions: Hypophosphatemia, X-linked Hypophosphatemia, Renin-angiotensin System, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT03493685

    Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)

    Not yet reported Travere Therapeutics, Inc. 371 participants Est. completion 2026-03-19 226 sites
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Status unknown NCT NCT03502031

    Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

    Not yet reported James A. Tumlin, MD 72 participants Est. completion 2024-10-01 2 sites
    Chronic kidney disease Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Status unknown NCT NCT03526042

    Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 40 participants Est. completion 2019-10-31 1 site Stand-alone
    Other conditions: Atherosclerosis, Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT03529838

    Hemodynamic and Salivary Responses of 12 Weeks of Training With Different Anti-hypertensive

    Not yet reported Federal University of Uberlandia 30 participants Est. completion 2021-03-01 1 site
    Other conditions: Hypertension, Menopause
    View official trial listing →
  • Status unknown NCT NCT03533153

    Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction

    Not yet reported, Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 90 participants Est. completion 2025-12-30 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03535935

    Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease

    Not yet reported, Not yet reported The University of Hong Kong 118 participants Est. completion 2022-12-31 2 sites Stand-alone
    Chronic kidney disease Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT03552575

    The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI

    Not yet reported NHS Greater Glasgow and Clyde 93 participants Est. completion 2020-07-25 2 sites Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03553303

    Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin

    Not yet reported Oslo University Hospital 40 participants Est. completion 2022-05 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03573102

    Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

    Not yet reported Nahla H Tohami 60 participants Est. completion 2020-07 1 site
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Terminated NCT NCT03604289

    Angiotensin 1-7 in Obesity Hypertension

    Not yet reported Amy Arnold 8 participants Est. completion 2023-06-03 1 site Stand-alone
    Other conditions: Obesity, Hypertension
    View official trial listing →
  • Completed NCT NCT03615196

    Study of the Safety of USB005 in Healthy Volunteers

    Not yet reported US Biotest, Inc. 32 participants Est. completion 2019-04-02 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03621111

    A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction

    Not yet reported Azienda ULSS 5 Polesana 120 participants Est. completion 2019-08-19 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03623529

    A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock

    Not yet reported La Jolla Pharmaceutical Company 100 participants Est. completion 2023-04 2 sites Stand-alone
    Other conditions: Catecholamine-resistant Hypotension (CRH), Distributive Shock, High Output Shock, Septic Shock
    View official trial listing →
  • Withdrawn NCT NCT03640221

    Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.

    Not yet reported Cedars-Sinai Medical Center Est. completion 2020-08-31 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03663127

    Evaluation of "Beauty Drink" on Regulation of Blood Pressure Effect by Clinical Trial

    Not yet reported Chung Shan Medical University 50 participants Est. completion 2019-06-30 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03667131

    Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.

    Not yet reported University of Guadalajara 59 participants Est. completion 2018-02-19 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT03686696

    Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

    Not yet reported Uppsala University 198 participants Est. completion 2023-08-22 32 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03695120

    RAAS Optimization for Acute CHF Patients

    Not yet reported University of Florida 1 participants Est. completion 2021-04-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT03714776

    A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously to Hypertensive Participants With Controlled Blood Pressure

    Not yet reported Ionis Pharmaceuticals, Inc. 25 participants Est. completion 2019-11-13 6 sites
    Other conditions: Mild Hypertension
    View official trial listing →
  • Completed NCT NCT03722524

    The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension

    Servier Russia 1247 participants Est. completion 2019-07-17 51 sites
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT03733145

    Angiotensin II in General Anesthesia

    Not yet reported Wake Forest University Health Sciences 32 participants Est. completion 2023-03-21 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03777215

    Angiotensin-(1-7) and Energy Expenditure in Human Obesity

    Not yet reported Amy Arnold 27 participants Est. completion 2026-04-15 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03785405

    Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

    Not yet reported Novartis Pharmaceuticals 216 participants Est. completion 2023-12-29 79 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT03804879

    Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

    Not yet reported Novartis Pharmaceuticals 83 participants Est. completion 2021-05-03 18 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT03816306

    Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients

    Mohammed Alnims 100 participants Est. completion 2019-12-01 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03821701

    Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 340 participants Est. completion 2022-01-31 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03826745

    The CHYMASE Angiotensin-(1-12) Axis in Cardiovascular Disease

    Trinity Hypertension & Metabolic Research Institute 75 participants Est. completion 2019-12-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03832660

    Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy

    Not yet reported Newcastle University 168 participants Est. completion 2022-06-30 5 sites
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Active, not recruiting NCT NCT03856632

    Liraglutide Effect in Atrial Fibrillation

    Not yet reported University of Miami 60 participants Est. completion 2026-12-31 1 site Added to GLP-1
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT03877783

    DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes

    Not yet reported Umeå University 10 participants Est. completion 2023-06-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Status unknown NCT NCT03887013

    Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease

    Not yet reported China National Center for Cardiovascular Diseases 226 participants Est. completion 2020-12 1 site
    Other conditions: Coronary Heart Disease, Diastolic Dysfunction
    View official trial listing →
  • Completed NCT NCT03888066

    Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)

    Not yet reported Vifor Pharma, Inc. 1195 participants Est. completion 2021-09-02 415 sites
    Other conditions: Hyperkalemia
    View official trial listing →
  • Status unknown NCT NCT03917758

    Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors

    Not yet reported University of Turin, Italy 30 participants Est. completion 2020-10-30 1 site
    Type 2 diabetes Other conditions: Arterial Hypertension, Body Weight Changes
    View official trial listing →
  • Completed NCT NCT03921736

    Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

    Not yet reported Anna Posadzy-Małaczyńska 180 participants Est. completion 2005-11-17
    Other conditions: Hypertension, Hyperuricemia, Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT03938389

    The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

    Not yet reported Ohio State University 90 participants Est. completion 2026-06 1 site
    Prediabetes Other conditions: Obesity, Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT03944447

    Outcomes Mandate National Integration With Cannabis as Medicine

    Not yet reported OMNI Medical Services, LLC 200000 participants Est. completion 2025-12-31 17 sites Stand-alone
    Other conditions: Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury, Chronic Pain Due to Trauma, Fibromyalgia, Seizures, Hepatitis C, Cancer, Crohn Disease, HIV/AIDS, Multiple Sclerosis, Traumatic Brain Injury, Sickle Cell Disease, Post Traumatic Stress Disorder, Tourette Syndrome, Ulcerative Colitis, Glaucoma, Epilepsy, Inflammatory Bowel Diseases, Parkinson Disease, Amyotrophic Lateral Sclerosis, Chronic Traumatic Encephalopathy, Anxiety, Depression, Insomnia, Autism, Opioid-use Disorder, Bipolar Disorder, Covid19, SARS-CoV Infection, COVID-19, Corona Virus Infection, Coronavirus
    View official trial listing →
  • Completed NCT NCT03949075

    Impact of Angiotensin Converting Enzyme Activity on Exercise Training Sensitivity

    Not yet reported University of Copenhagen 52 participants Est. completion 2019-12-30 1 site
    Other conditions: Exercise, Angiotensin-Converting Enzyme Inhibitors
    View official trial listing →
  • Status unknown NCT NCT03951142

    Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study

    Not yet reported Kyrre Eeg Emblem 165 participants Est. completion 2024-12-31 1 site
    Other conditions: Glioblastoma, Brain Metastases
    View official trial listing →
  • Completed NCT NCT03952390

    Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 53 participants Est. completion 2019-12-15 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Completed NCT NCT03953872

    Antihypertensives in Non-cardiac Surgical Population

    RenJi Hospital 351 participants Est. completion 2019-04-01 1 site
    Other conditions: Perioperative Antihypertensive
    View official trial listing →
  • Status unknown NCT NCT03953950

    Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients

    Not yet reported Chiang Mai University 84 participants Est. completion 2020-12 1 site
    Other conditions: End Stage Renal Disease, Peritoneal Dialysis
    View official trial listing →
  • Withdrawn NCT NCT03957161

    ACEi ARB Withdrawal in CKD Patients

    Not yet reported University of California, San Francisco Est. completion 2023-11 1 site
    Chronic kidney disease Other conditions: Blood Pressure, Angiotensin-converting Enzyme Inhibitor, Angiotensin Receptor Blockers
    View official trial listing →
  • Completed NCT NCT03979976

    Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus

    Not yet reported, Not yet reported Federal University of São Paulo 37 participants Est. completion 2013-09 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Withdrawn NCT NCT04021550

    Improving 24-hour Blood Pressure in Obstructive Sleep Apnea

    Not yet reported University of British Columbia Est. completion 2026-12 Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT04023227

    Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

    Not yet reported Novartis Pharmaceuticals 922 participants Est. completion 2025-03-31 79 sites Stand-alone
    Heart failure Other conditions: Chagas Disease
    View official trial listing →
  • Completed NCT NCT04036409

    Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients

    Not yet reported Hospital Israelita Albert Einstein 4368 participants Est. completion 2026-07-08 30 sites Stand-alone
    Cardiovascular disease Other conditions: Blood Pressure, Cognitive Impairment, Vascular Diseases
    View official trial listing →
  • Completed NCT NCT04040634

    Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)

    Not yet reported Hospital Israelita Albert Einstein 9476 participants Est. completion 2026-07-08 32 sites Stand-alone
    Cardiovascular disease Other conditions: Diabetes Mellitus, High Blood Pressure, Cognitive Impairment
    View official trial listing →
  • Withdrawn NCT NCT04048707

    Angiotensin 2 for Hepatorenal Syndrome

    Not yet reported University of California, Los Angeles Est. completion 2023-07-01 Stand-alone
    Other conditions: Hepatorenal Syndrome, Cirrhosis, Kidney Failure, Acute
    View official trial listing →
  • Completed NCT NCT04053764

    Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease

    Not yet reported Novartis Pharmaceuticals 58 participants Est. completion 2023-03-20 24 sites Stand-alone
    Other conditions: Sickle Cell Disease (SCD)
    View official trial listing →
  • Completed NCT NCT04061824

    Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

    Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04063930

    The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia

    Not yet reported Steno Diabetes Center Copenhagen 20 participants Est. completion 2021-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04076930

    Effects of Renin-Angiotensin System Inhibitors in Peritoneal Dialysis Patients

    Chiang Mai University 1468 participants Est. completion 2020-03 1 site
    Other conditions: Peritoneal Dialysis
    View official trial listing →
  • Completed NCT NCT04083222

    A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx

    Not yet reported Ionis Pharmaceuticals, Inc. 26 participants Est. completion 2020-07-20 9 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT04092309

    Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

    Not yet reported University of Athens 90 participants Est. completion 2021-09-01 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Cardiotoxicity
    View official trial listing →
  • Completed NCT NCT04104490

    Angiotensin Converting Enzyme (ACE2), Brain, Gut Dysbiosis in Pulmonary Hypertension

    University of Florida 79 participants Est. completion 2021-12-31 2 sites
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT04129840

    Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa

    Not yet reported University Hospital, Basel, Switzerland 1268 participants Est. completion 2022-09-22 3 sites
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT04141800

    Spanish Study of Hyperkalaemia Incidence and Prognosis in Patients With Heart Failure and Reduced Ejection Fraction

    Spanish Society of Cardiology 565 participants Est. completion 2021-03-31 1 site
    Heart failure Other conditions: Hyperkalemia
    View official trial listing →
  • Terminated NCT NCT04149990

    Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

    Not yet reported Jacob Moller 51 participants Est. completion 2023-06-06 2 sites
    Cardiovascular disease Other conditions: Diastolic Dysfunction
    View official trial listing →
  • Withdrawn NCT NCT04206865

    Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output

    Not yet reported The Cleveland Clinic Est. completion 2020-09-10 1 site
    Other conditions: Cardiogenic Shock
    View official trial listing →
  • Status unknown NCT NCT04213963

    Prospective Study on Primary Aldosteronism in Resistant Hypertension

    University of Turin, Italy 100 participants Est. completion 2025-10-31 1 site
    Other conditions: Resistant Hypertension, Primary Aldosteronism, Refractory Hypertension, Hypertensive End-Organ Damage, Atrial Fibrillation, Aortic Ectasia
    View official trial listing →
  • Status unknown NCT NCT04217135

    The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation

    Not yet reported Kaohsiung Veterans General Hospital. 400 participants Est. completion 2022-07-31 1 site
    Heart failure Other conditions: Mitral Regurgitation
    View official trial listing →
  • Completed NCT NCT04218435

    Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients

    Clinision 200 participants Est. completion 2020-12-30 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT04222686

    Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients

    Not yet reported Yaounde Central Hospital 23 participants Est. completion 2018-04-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04245644

    Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

    Massimo Falconi 800 participants Est. completion 2024-12-31 1 site
    Other conditions: Disease Free Survival, Overall Survival, Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT04249648

    Hyperkalaemia and Its Impact on Therapy with RAASi

    Portsmouth Hospitals NHS Trust 651 participants Est. completion 2024-11-01 1 site
    Heart failure Other conditions: Hyperkalaemia, Left Ventricular Systolic Dysfunction
    View official trial listing →
  • Completed NCT NCT04254042

    Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients.

    Not yet reported Yaounde Central Hospital 24 participants Est. completion 2019-05-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT04270071

    Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris

    Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 80 participants Est. completion 2021-12 Stand-alone
    Other conditions: Coronary Heart Disease, Stable Angina
    View official trial listing →
  • Status unknown NCT NCT04270279

    Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris

    Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 120 participants Est. completion 2021-10 Stand-alone
    Other conditions: Coronary Heart Disease, Stable Angina
    View official trial listing →
  • Withdrawn NCT NCT04287686

    Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19

    Not yet reported The First Affiliated Hospital of Guangzhou Medical University Est. completion 2020-04 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04318418

    ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19

    Neuromed IRCCS 3400 participants Est. completion 2020-06-30 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04320589

    the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

    Not yet reported National Cancer Institute, Egypt 30 participants Est. completion 2021-08-30 1 site
    Other conditions: Pheochromocytoma
    View official trial listing →
  • Status unknown NCT NCT04322786

    The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?

    University College, London 1302508 participants Est. completion 2021-03-31
    Other conditions: Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Status unknown NCT NCT04331574

    Renin-Angiotensin System Inhibitors and COVID-19

    Societa Italiana dell'Ipertensione Arteriosa 2000 participants Est. completion 2020-04-30 1 site
    Cardiovascular disease Other conditions: COVID-19, Hypertension
    View official trial listing →
  • Status unknown NCT NCT04332666

    Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial

    Not yet reported, Not yet reported Erasme University Hospital 60 participants Est. completion 2023-06-15 Stand-alone
    Other conditions: Coronavirus, Respiratory Failure, Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere, SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT04334824

    Hydrochlorothiazide and Risk of Skin Cancer

    Canadian Network for Observational Drug Effect Studies, CNODES 2953748 participants Est. completion 2021-03-05 1 site
    Other conditions: Non-melanoma Skin Cancer, Melanoma, Hypertension
    View official trial listing →
  • Completed NCT NCT04335136

    Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19

    Not yet reported Apeiron Biologics 185 participants Est. completion 2020-12-26 22 sites
    Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT04335786

    Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

    Not yet reported Radboud University Medical Center 23 participants Est. completion 2021-05-25 7 sites
    Other conditions: Acute Respiratory Distress Syndrome, SARS-CoV-2, COVID, COVID-19, Severe Acute Respiratory Syndrome
    View official trial listing →
  • Status unknown NCT NCT04337008

    Renin Angiotensin System - CoronaVirus

    Not yet reported Assistance Publique Hopitaux De Marseille 50 participants Est. completion 2020-07-31 1 site
    Other conditions: COVID 19
    View official trial listing →
  • Status unknown NCT NCT04337190

    Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)

    University Hospital, Angers 100 participants Est. completion 2020-12-06 1 site
    Other conditions: COVID, Acute Respiratory Distress Syndrome
    View official trial listing →
  • Completed NCT NCT04338009

    Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019

    Not yet reported University of Pennsylvania 152 participants Est. completion 2020-08-20 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04340557

    Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

    Not yet reported Sharp HealthCare 31 participants Est. completion 2020-06-13 3 sites
    Other conditions: SARS-CoV Infection
    View official trial listing →
  • Not yet recruiting NCT NCT04345406

    Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

    Not yet reported Tanta University 60 participants Est. completion 2029-12-01 1 site
    Other conditions: COVID
    View official trial listing →
  • Completed NCT NCT04351581

    Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19

    Not yet reported University Hospital, Gentofte, Copenhagen 78 participants Est. completion 2022-12-22 2 sites
    Other conditions: Covid-19
    View official trial listing →
  • Status unknown NCT NCT04351724

    Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)

    Not yet reported, Not yet reported Medical University of Vienna 500 participants Est. completion 2022-03-31 9 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04353596

    Stopping ACE-inhibitors in COVID-19

    Not yet reported Medical University Innsbruck 216 participants Est. completion 2021-02-24 31 sites Stand-alone
    Other conditions: SARS-CoV-2, COVID-19
    View official trial listing →
  • Status unknown NCT NCT04356417

    Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse

    Assistance Publique - Hôpitaux de Paris 6000000 participants Est. completion 2020-06 1 site
    Other conditions: AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection
    View official trial listing →
  • Completed NCT NCT04357535

    Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives

    Hakeam Abdulaziz Hakeam 314 participants Est. completion 2020-08-01 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT04360551

    Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients

    Not yet reported University of Hawaii 24 participants Est. completion 2022-04-26 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04364113

    The Modification of Diet in Renal Disease Study

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 840 participants Est. completion 2000-12-31 Stand-alone
    Other conditions: Chronic Renal Disease
    View official trial listing →
  • Completed NCT NCT04364139

    African American Study of Kidney Disease and Hypertension

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1094 participants Est. completion 2007-06-30 Stand-alone
    Other conditions: Hypertensive Nephrosclerosis, Chronic Renal Insufficiency
    View official trial listing →
  • Status unknown NCT NCT04364893

    Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19

    Not yet reported D'Or Institute for Research and Education 700 participants Est. completion 2020-12-01 1 site
    Other conditions: Corona Virus Infection, COVID-19
    View official trial listing →
  • Completed NCT NCT04364984

    ARB, ACEi, DRi Effects on COVID-19 Course Disease

    Medical Practice Prof D. Ivanov 112 participants Est. completion 2021-08-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04366765

    COVID-19 Survival - The COVIVA Study

    University Hospital, Basel, Switzerland 1325 participants Est. completion 2021-06-30 1 site
    Other conditions: COVID-19, SARS-CoV 2
    View official trial listing →
  • Completed NCT NCT04367051

    Pilot Study on Withdrawal of Spironolactone Among Heart Failure With Improved Ejection Fraction

    Not yet reported Asan Medical Center 62 participants Est. completion 2022-06-30 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT04371289

    Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up

    Istituto Auxologico Italiano 4356 participants Est. completion 2021-09-10 1 site
    Other conditions: COVID-19, Cardiovascular Risk Factor
    View official trial listing →
  • Status unknown NCT NCT04374110

    Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19

    National Institute of Cardiology, Warsaw, Poland 1000 participants Est. completion 2021-08-24 1 site
    Cardiovascular disease Other conditions: COVID, Hypertension, Cardiovascular Risk Factor
    View official trial listing →
  • Status unknown NCT NCT04374695

    Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19

    Versailles Hospital 700 participants Est. completion 2020-07-01
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04375124

    Treatment of Angiotensin Peptide (1-7) for COVID-19

    Not yet reported Kanuni Sultan Suleyman Training and Research Hospital 9 participants Est. completion 2020-09-30 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04378387

    Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in Primary Aldosteronism

    University of Turin, Italy 60 participants Est. completion 2020-04-30 1 site
    Other conditions: Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
    View official trial listing →
  • Completed NCT NCT04379310

    Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)

    Istanbul Nisantasi University 54 participants Est. completion 2020-05-08 1 site
    Other conditions: Covid-19
    View official trial listing →
  • Completed NCT NCT04394117

    Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

    Not yet reported The George Institute 787 participants Est. completion 2022-01-17 22 sites
    Other conditions: Coronavirus Disease 2019, COVID-19
    View official trial listing →
  • Completed NCT NCT04397302

    Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction

    Italian Society of Cardiology 652 participants Est. completion 2020-03-16 1 site
    Heart failure Other conditions: Left Ventricular Dysfunction, Ventricular Remodeling
    View official trial listing →
  • Status unknown NCT NCT04401228

    Predictive Models for Intensive Care Admission and Death of COVID-19

    Clinique Saint Pierre Ottignies 60 participants Est. completion 2021-01-01 1 site
    Other conditions: COVID19, Pneumonia, Viral, Inflammatory Response
    View official trial listing →
  • Completed NCT NCT04401423

    TXA127 for the Treatment of Severe COVID-19

    Not yet reported Columbia University 22 participants Est. completion 2021-06-10 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04403932

    Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency

    Hospital San Carlos, Madrid 300 participants Est. completion 2020-08-01 1 site
    Other conditions: Coronavirus Disease 2019 (COVID-19)
    View official trial listing →
  • Status unknown NCT NCT04408326

    Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome

    Guy's and St Thomas' NHS Foundation Trust 50 participants Est. completion 2022-12-31 1 site
    Other conditions: COVID, Acute Respiratory Distress Syndrome
    View official trial listing →
  • Completed NCT NCT04419610

    RAS and Coagulopathy in COVID19

    Not yet reported Imperial College London 28 participants Est. completion 2021-05-12 1 site
    Other conditions: COVID
    View official trial listing →
  • Status unknown NCT NCT04434365

    Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

    Not yet reported, Not yet reported Peking Union Medical College Hospital 24 participants Est. completion 2020-12-30 1 site Stand-alone
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention
    View official trial listing →
  • Status unknown NCT NCT04458285

    Efficacy and Safety of Sacubitril/Valsartan in Maintenance Hemodialysis Patients With Heart Failure

    Not yet reported Guangdong Provincial People's Hospital 118 participants Est. completion 2020-12-31 1 site Stand-alone
    Heart failure Other conditions: Hemodialysis Complication
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Status unknown NCT NCT04473703

    Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients

    Shanghai Chest Hospital 300 participants Est. completion 2023-08-01
    Other conditions: Adverse Reactions, Immune Checkpoint Inhibitor, Non-Small Cell Lung Cancer Patients, Cardiac Event
    View official trial listing →
  • Terminated NCT NCT04491136

    Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)

    Not yet reported Novartis Pharmaceuticals 201 participants Est. completion 2023-06-08 23 sites Stand-alone
    Heart failure
    View official trial listing →
  • Terminated NCT NCT04493359

    Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19

    Not yet reported, Not yet reported University of Sao Paulo 18 participants Est. completion 2021-09-28 1 site Stand-alone
    Other conditions: Covid19, Angiotensin II Receptor Antagonist Adverse Reaction
    View official trial listing →
  • Completed NCT NCT04498780

    Hemodynamic Effects of ARNI on Noninvasive Pressure-volume Analysis in Patients With Chronic Heart Failure

    University of Leipzig 117 participants Est. completion 2026-04-08 2 sites
    Heart failure
    View official trial listing →
  • Terminated NCT NCT04506372

    Management of Angiotensin Inhibitors During the Perioperative Period

    Not yet reported UMC Utrecht 342 participants Est. completion 2023-09-01 7 sites Stand-alone
    Other conditions: Surgery, Angiotensin Hypertension, Perioperative Complication
    View official trial listing →
  • Completed NCT NCT04508985

    The McGill RAAS-COVID-19 Trial

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 46 participants Est. completion 2021-04-17 1 site
    Cardiovascular disease Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04510623

    Host Response Mediators in Coronavirus (COVID-19) Infection

    University of British Columbia 500 participants Est. completion 2022-06-30 15 sites
    Other conditions: COVID-19, SARS-CoV2
    View official trial listing →
  • Withdrawn NCT NCT04510792

    IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors

    Portsmouth Hospitals NHS Trust Est. completion 2021-07-12 1 site
    Other conditions: Hyperkalemia
    View official trial listing →
  • Status unknown NCT NCT04519398

    Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events

    Grigore T. Popa University of Medicine and Pharmacy 60 participants Est. completion 2021-08-18 1 site
    Other conditions: Covid19, Corona Virus Infection, Thrombosis, ARDS, Thrombophilia, Thromboses, Intracranial, Thromboses, Deep Vein, RAAS
    View official trial listing →
  • Status unknown NCT NCT04524156

    COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2

    Not yet reported Erasme University Hospital 100 participants Est. completion 2023-05-04 1 site
    Other conditions: COVID, Acute Respiratory Distress Syndrome, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT04524494

    Human Intestinal Amino Acid Absorption and the Role of a Local RAS

    University Children's Hospital Basel 50 participants Est. completion 2011-05-31 2 sites
    Other conditions: Renin-Angiotensin Aldosterone System (RAS)
    View official trial listing →
  • Completed NCT NCT04529005

    Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients

    Not yet reported University of Illinois at Chicago 20 participants Est. completion 2021-08-01 1 site Stand-alone
    Other conditions: Shock, Surgical, Shock, Hypotension and Shock, Kidney Transplant; Complications, Intraoperative Hypotension, Postoperative Hypotension
    View official trial listing →
  • Withdrawn NCT NCT04531397

    Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

    Not yet reported Children's Hospital of Fudan University Est. completion 2022-12-31 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Status unknown NCT NCT04537585

    COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7

    Not yet reported Guyguy K Tshima, MD 2000 participants Est. completion 2022-12 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04538924

    Etiologic Mechanisms, Myocardial Changes and Prognosis of Patients With MINOCA

    Not yet reported Vilnius University Hospital Santaros Klinikos 150 participants Est. completion 2023-01-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04558359

    Renin and Renal Biomarker Response to Angiotensin II

    Not yet reported Alexander Flannery 30 participants Est. completion 2023-07-30 1 site Stand-alone
    Other conditions: Septic Shock, Acute Kidney Injury
    View official trial listing →
  • Withdrawn NCT NCT04570501

    Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients

    Not yet reported, Not yet reported Stanford University Est. completion 2022-08 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04582097

    Ramipril in Pediatric Patients on Hemodialysis

    Not yet reported, Not yet reported Ain Shams University 135 participants Est. completion 2020-02-28 1 site Stand-alone
    Other conditions: Hemodialysis
    View official trial listing →
  • Completed NCT NCT04583228

    Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects

    Not yet reported Hengenix Biotech Inc 32 participants Est. completion 2021-07-20 1 site
    Other conditions: COVID 19
    View official trial listing →
  • Completed NCT NCT04587375

    Diagnosis of Endocrine Dysfunctions in Covid-19

    University Hospital, Montpellier 50 participants Est. completion 2020-05-30 1 site
    Other conditions: Covid 19
    View official trial listing →
  • Completed NCT NCT04591210

    The COVID-RASi Trial (COVID-19)

    Not yet reported Ottawa Heart Institute Research Corporation 372 participants Est. completion 2024-12-30 31 sites Stand-alone
    Cardiovascular disease Other conditions: COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT04592744

    Angiotensin 2 for AKI After OLT

    Not yet reported University of California, Los Angeles 30 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury, Liver Transplant; Complications
    View official trial listing →
  • Status unknown NCT NCT04604938

    The Effects of Losartan on Reward Reinforcement Learning

    Not yet reported University of Electronic Science and Technology of China 60 participants Est. completion 2022-03-31 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04605887

    Angiotensin 1-7 as a Therapy in the Treatment of COVID-19

    Not yet reported Rambam Health Care Campus 120 participants Est. completion 2024-04 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04606225

    Losartan Effects on Emotion-memory Interaction

    Not yet reported University of Electronic Science and Technology of China 60 participants Est. completion 2022-03-31 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT04606563

    Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

    Not yet reported University of British Columbia 341 participants Est. completion 2022-04-22 13 sites
    Other conditions: Covid19, SARS-CoV Infection
    View official trial listing →
  • Completed NCT NCT04632589

    Losartan for Improved Vascular Endothelial Function After Preeclampsia

    Not yet reported Anna Stanhewicz, PhD 11 participants Est. completion 2025-03-13 1 site
    Other conditions: Preeclampsia Postpartum
    View official trial listing →
  • Completed NCT NCT04633772

    Use of Angiotensin-(1-7) in COVID-19

    Not yet reported, Not yet reported Erasme University Hospital 112 participants Est. completion 2021-11-01 2 sites Stand-alone
    Other conditions: Infection, Coronavirus, Respiratory Failure
    View official trial listing →
  • Withdrawn NCT NCT04640610

    Angiotensin-converting Enzyme 2 (ACE2) Expression in Tonsils and Adenoids

    Assistance Publique - Hôpitaux de Paris Est. completion 2021-06-30 9 sites
    Other conditions: Adenoidectomy, Tonsillectomy
    View official trial listing →
  • Terminated NCT NCT04643691

    Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS

    Not yet reported Assistance Publique Hopitaux De Marseille 78 participants Est. completion 2021-12-07 1 site
    Other conditions: COVID-19, ARDS
    View official trial listing →
  • Status unknown NCT NCT04647292

    European Blood Pressure Intensive Control After Stroke

    Not yet reported University College Dublin 142 participants Est. completion 2026-03 1 site Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Completed NCT NCT04647396

    Biomarker-guided Intervention to Prevent Acute Kidney Injury

    Not yet reported University Hospital Muenster 1180 participants Est. completion 2024-09-09 37 sites Stand-alone
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT04647552

    Effects of Hydrocortison Treatment on Angiotensin II and Angiotensin II Receptors in Patients With Septic Shock

    Inonu University 40 participants Est. completion 2021-02-06 2 sites
    Other conditions: Shock, Septic
    View official trial listing →
  • Terminated NCT NCT04679311

    Treatment of Angiotensin Converting Enzyme Inhibitor-induced Angioedema

    Not yet reported Washington University School of Medicine 2 participants Est. completion 2023-01-31 1 site
    Other conditions: Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
    View official trial listing →
  • Status unknown NCT NCT04687111

    Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation

    Not yet reported Mark Ledwidge 250 participants Est. completion 2021-06-11 2 sites Stand-alone
    Other conditions: Atrial Remodeling, Myocardial Dysfunction, Left Ventricular Remodeling, Left Ventricular Diastolic Dysfunction, Hypertension, Cardiovascular Morbidity, Fibrosis Myocardial, Inflammatory Myopathy, Atrial Arrhythmia
    View official trial listing →
  • Completed NCT NCT04707508

    Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus

    Not yet reported Nantou Christian Hospital 203 participants Est. completion 2019-11-29 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04714320

    A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

    Not yet reported Ionis Pharmaceuticals, Inc. 160 participants Est. completion 2022-10-03 50 sites
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT04715763

    INvestigating TELmisartin Study

    Not yet reported University of Hawaii 24 participants Est. completion 2022-04-26 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04716842

    Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.

    Inonu University 75 participants Est. completion 2021-04 1 site
    Other conditions: Sepsis, Septic Shock
    View official trial listing →
  • Completed NCT NCT04736433

    Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.

    Brigham and Women's Hospital 6066 participants Est. completion 2021-02-18 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04743063

    Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

    Brigham and Women's Hospital 40000 participants Est. completion 2022-12-31 1 site
    Heart failure Other conditions: Frailty
    View official trial listing →
  • Completed NCT NCT04753112

    Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device

    Not yet reported Germans Trias i Pujol Hospital 14 participants Est. completion 2021-09-20 1 site Stand-alone
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT04766645

    ACE2 Gender Differences in Stroke With COVID-19

    Fondazione Don Carlo Gnocchi ETS 77 participants Est. completion 2023-01-31 1 site
    Other conditions: Neurologic Manifestations
    View official trial listing →
  • Status unknown NCT NCT04769778

    Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine

    Not yet reported Josep M Cruzado 180 participants Est. completion 2023-06 1 site
    Other conditions: Chronic Kidney Allograft Nephropathy
    View official trial listing →
  • Terminated NCT NCT04778059

    Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

    Not yet reported US Biotest, Inc. 21 participants Est. completion 2022-05-10 1 site Stand-alone
    Other conditions: 2019 Novel Coronavirus Infection, COVID-19 Virus Infection, SARS Coronavirus 2 Infection, SARS-CoV-2 Infection, Respiratory Distress Syndrome, Adult, Adult Respiratory Distress Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT04789733

    The GUARDIAN Pilot Trial

    Not yet reported The Cleveland Clinic 80 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: General Surgery
    View official trial listing →
  • Completed NCT NCT04818801

    Safety, Reactogenicity and Immunogenicity Study of ReCOV

    Not yet reported Jiangsu Rec-Biotechnology Co., Ltd. 100 participants Est. completion 2022-05-05 2 sites Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Terminated NCT NCT04828161

    A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19

    Not yet reported, Not yet reported Novartis Pharmaceuticals 407 participants Est. completion 2022-01-27 48 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04836182

    A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction

    Not yet reported Ionis Pharmaceuticals, Inc. 72 participants Est. completion 2023-01-11 19 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT04838470

    Prognosis Predictors for Heart Failure

    Chang Gung Memorial Hospital 792 participants Est. completion 2021-03-30
    Heart failure Other conditions: Rehabilitation, Morality, Hospitalization, Life Quality
    View official trial listing →
  • Status unknown NCT NCT04842058

    Pathophysiologic Hemodynamics After Primary Unilateral Total Hip Arthroplasty in Patients Receiving ACEIs and ARBs

    Hvidovre University Hospital 24 participants Est. completion 2023-12-01 1 site
    Other conditions: Orthostatic Intolerance, Orthostatic Hypotension
    View official trial listing →
  • Status unknown NCT NCT04853758

    Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.

    Not yet reported University of Sao Paulo General Hospital 200 participants Est. completion 2024-12-01 1 site
    Other conditions: Chagas Cardiomyopathy
    View official trial listing →
  • Terminated NCT NCT04870164

    Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)

    Not yet reported Molecular Partners AG 53 participants Est. completion 2022-01-06 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04881123

    SER150 vs Placebo in Diabetic Kidney Disease

    Not yet reported, Not yet reported Serodus AS 20 participants Est. completion 2024-06-06 12 sites
    Chronic kidney disease
    View official trial listing →
  • Withdrawn NCT NCT04899206

    ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA

    Sebastian Videla Est. completion 2025-12-20 1 site
    Other conditions: ACE Inhibitors, ARB, Hypertension, Depression
    View official trial listing →
  • Active, not recruiting NCT NCT04901169

    Angiotensin II in Liver Transplantation

    Not yet reported, Not yet reported University of California, San Francisco 50 participants Est. completion 2027-03-18 1 site Stand-alone
    Other conditions: Liver Transplant; Complications, Vasoplegia
    View official trial listing →
  • Terminated NCT NCT04904562

    Angiotensin II for Distributive Shock

    Not yet reported Northwestern University 2 participants Est. completion 2024-07-01 1 site
    Other conditions: Distributive Shock
    View official trial listing →
  • Status unknown NCT NCT04912167

    The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction

    Not yet reported West China Hospital 376 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: STEMI
    View official trial listing →
  • Status unknown NCT NCT04915053

    Black Garlic Nutraceuticals and Blood Pressure Control

    Not yet reported Universitat de Lleida 100 participants Est. completion 2022-06-30 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04924660

    Novel Experimental COVID-19 Therapies Affecting Host Response

    Not yet reported, Not yet reported Sean Collins 1060 participants Est. completion 2023-12-31 51 sites
    Other conditions: COVID-19, SARS-CoV-2 Infection, Coronavirus Infection
    View official trial listing →
  • Status unknown NCT NCT04929600

    Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.

    Not yet reported Shanghai Jiao Tong University School of Medicine 120 participants Est. completion 2023-12 1 site
    Other conditions: Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT04936035

    A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension

    Not yet reported Alnylam Pharmaceuticals 394 participants Est. completion 2024-12-05 75 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05007054

    Long-Term Outcomes in Patients With Three-Vessel Disease

    The First Affiliated Hospital of Dalian Medical University 4300 participants Est. completion 2021-08-06 1 site
    Other conditions: Three Vessel Coronary Disease
    View official trial listing →
  • Status unknown NCT NCT05007262

    Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

    Not yet reported Guizhou Bailing Group Pharmaceutical Co Ltd 240 participants Est. completion 2023-12-31 13 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT05021419

    Efficacy of a Streamlined Heart Failure Optimization Protocol

    Not yet reported The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust 60 participants Est. completion 2024-01-07 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT05043610

    MSCs for Prevention of MI-induced HF

    Not yet reported Shiraz University of Medical Sciences 420 participants Est. completion 2024-11-01 3 sites Stand-alone
    Cardiovascular diseaseHeart failure Other conditions: Cardiac Remodeling, Ventricular, STEMI, Regenerative Medicine
    View official trial listing →
  • Status unknown NCT NCT05045274

    The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction

    Not yet reported Assiut University 300 participants Est. completion 2022-09
    Cardiovascular disease Other conditions: Left Ventricular Systolic Dysfunction
    View official trial listing →
  • Completed NCT NCT05049616

    Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 70 participants Est. completion 2023-09-01 1 site
    Other conditions: Hypertension in Pregnancy, Postpartum Preeclampsia
    View official trial listing →
  • Status unknown NCT NCT05053893

    Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome

    Not yet reported The Affiliated Hospital of Qingdao University 40 participants Est. completion 2022-09-01 1 site
    Other conditions: Cardio-Renal Syndrome
    View official trial listing →
  • Completed NCT NCT05055570

    Angiotensin II Pathway and Postoperative Hypoxemia

    Beijing Anzhen Hospital 88 participants Est. completion 2022-06-01 1 site
    Other conditions: Aortic Dissection
    View official trial listing →
  • Status unknown NCT NCT05064904

    Multidiscipline Care for Acute Kidney Disease (AKD)

    Not yet reported National Taiwan University Hospital 300 participants Est. completion 2024-02-15 7 sites
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT05065645

    Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19

    Not yet reported Apeiron Biologics 40 participants Est. completion 2022-05-27 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT05087940

    Treatment of Resistant Hypertension: Cohort Study

    Galenika AD Beograd 731 participants Est. completion 2022-12-31 12 sites
    Other conditions: Resistant Hypertension
    View official trial listing →
  • Status unknown NCT NCT05089539

    The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF

    Not yet reported Chongqing Medical University 60 participants Est. completion 2022-04-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05096039

    Role of Sacubitril/Valsartan in Improving Provider Performance in Managing Heart Failure Under Medicare Alternative Payment Models

    Novartis Pharmaceuticals 1614719 participants Est. completion 2020-09-30 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT05096143

    A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

    Novartis Pharmaceuticals 42269 participants Est. completion 2020-10-19 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT05103332

    Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

    Not yet reported Alnylam Pharmaceuticals 663 participants Est. completion 2024-09-13 110 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05115383

    Effects of Exercise on the Renin-angiotensin System

    Not yet reported Western University, Canada 24 participants Est. completion 2023-04-30 1 site
    Other conditions: COVID-19 Acute Respiratory Distress Syndrome
    View official trial listing →
  • Terminated NCT NCT05117736

    ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure

    Not yet reported Montreal Heart Institute 15 participants Est. completion 2023-03-12 1 site
    Heart failure Other conditions: Systemic Right Ventricle
    View official trial listing →
  • Terminated NCT NCT05122182

    Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19

    Not yet reported University of Sydney 49 participants Est. completion 2023-01-28 10 sites Stand-alone
    Other conditions: COVID-19, SARS-CoV2 Infection
    View official trial listing →
  • Status unknown NCT NCT05132712

    Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial

    Not yet reported Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi 100 participants Est. completion 2022-09-30 1 site
    Other conditions: Vascular Access Complication
    View official trial listing →
  • Not yet recruiting NCT NCT05133050

    Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 510 participants Est. completion 2026-12-31 1 site
    Other conditions: Alport Syndrome
    View official trial listing →
  • Withdrawn NCT NCT05157464

    Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty

    Not yet reported NYU Langone Health Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Arthrofibrosis
    View official trial listing →
  • Status unknown NCT NCT05164653

    Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

    Not yet reported Saga University 400 participants Est. completion 2025-03 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT05168787

    Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction

    Methodist Health System 6558 participants Est. completion 2025-07-08 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT05169411

    Preserving Kidney Function in Children With Chronic Kidney Disease

    Children's Hospital of Philadelphia 20240 participants Est. completion 2024-07-31 1 site
    Chronic kidney disease Other conditions: Pediatric Kidney Disease
    View official trial listing →
  • Status unknown NCT NCT05173025

    Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension

    Not yet reported Seoul National University Bundang Hospital 42 participants Est. completion 2023-12-31 1 site
    Type 2 diabetes Other conditions: Hypertension, Atherosclerosis, Renin Hypertension
    View official trial listing →
  • Completed NCT NCT05189015

    Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension

    Not yet reported Seoul National University Bundang Hospital 80 participants Est. completion 2023-06-30 1 site
    Type 2 diabetes Other conditions: Angiotensin/Renin/Aldosterone Hypertension, Hypertension
    View official trial listing →
  • Withdrawn NCT NCT05193370

    Angiotensin II vs. Vasopressin in Septic Shock

    Not yet reported University of New Mexico Est. completion 2022-11-30 1 site Stand-alone
    Other conditions: Septic Shock
    View official trial listing →
  • Active, not recruiting NCT NCT05196035

    A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

    Not yet reported Bayer 219 participants Est. completion 2027-05-10 132 sites
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT05199493

    Reducing Acute Kidney Injury Occurence by Administering Angiotensin II

    Not yet reported Universität Münster 64 participants Est. completion 2023-03-19 1 site Stand-alone
    Other conditions: Cardiac Surgery, Vasoplegia, Hyperreninemia
    View official trial listing →
  • Completed NCT NCT05212649

    Optimized Peak VO2 in Predicting Advanced HF

    Chang Gung Memorial Hospital 377 participants Est. completion 2021-07-30 1 site
    Heart failure Other conditions: Morality, Transplant; Failure, Heart
    View official trial listing →
  • Status unknown NCT NCT05222542

    Angiotensin Metabolite Profile After Subarachnoid Hemorrhage

    Dr. Roman Ullrich 60 participants Est. completion 2025-02 1 site
    Other conditions: Subarachnoid Hemorrhage, Aneurysmal
    View official trial listing →
  • Status unknown NCT NCT05232201

    Vitamin D Levels and Heart Rate Variability on Endothelial Function Via RAAS Augmentation in OSA

    University Malaysia Sarawak 150 participants Est. completion 2024-08 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT05232370

    The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

    Not yet reported Unidad de Investigacion Medica en Enfermedades Renales 39 participants Est. completion 2022-01-06 1 site Stand-alone
    Other conditions: Oxidative Stress
    View official trial listing →
  • Completed NCT NCT05237323

    Micophenolate Mofetil Versus Azathioprine in Myocarditis

    Not yet reported I.M. Sechenov First Moscow State Medical University 50 participants Est. completion 2025-07-10 1 site Stand-alone
    Heart failureSubstance use disorder Other conditions: Lymphocytic Myocarditis (Disorder), Dilated Cardiomyopathy, Cardiomyopathies
    View official trial listing →
  • Status unknown NCT NCT05240443

    Bariatric Surgery and Chronic Renal Disease

    Not yet reported McMaster University 60 participants Est. completion 2023-06-01 1 site Stand-alone
    Chronic kidney disease Other conditions: Bariatric Surgery, Obesity
    View official trial listing →
  • Status unknown NCT NCT05243446

    Cardiorenal Effecs of Losartan in Kidney Transplant Recipients

    Medical University of Gdansk 740 participants Est. completion 2023-12-31 1 site
    Other conditions: Renal Transplant Failure, Cardiovascular Complication
    View official trial listing →
  • Withdrawn NCT NCT05259137

    Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars

    Not yet reported, Not yet reported Nova Scotia Health Authority Est. completion 2026-10
    Other conditions: Hypertrophic Scar
    View official trial listing →
  • Completed NCT NCT05260658

    Safety and Tolerability of CFTX-1554 in Healthy Subjects

    Not yet reported Confo Therapeutics 97 participants Est. completion 2023-02-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05269615

    Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II

    Not yet reported The University of Hong Kong 80 participants Est. completion 2024-09-30 1 site
    Other conditions: Exercise Physiology
    View official trial listing →
  • Status unknown NCT NCT05271448

    Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

    Not yet reported An-Najah National University 600 participants Est. completion 2024-08-01 1 site
    Chronic kidney disease Other conditions: Contrast-induced Nephropathy, Ischemic Heart Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05272878

    Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.

    Not yet reported Assistance Publique - Hôpitaux de Paris 508 participants Est. completion 2026-06-27 1 site
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Status unknown NCT NCT05298657

    The Angiotensin-Melatonin Axis in Poor and Hyper Responders for IVF Treatment

    Fatima College of Health Sciences 200 participants Est. completion 2024-08-31 1 site
    Other conditions: Poor Response to Ovulation Induction, PCOS, Endometriosis, Infertility, Female
    View official trial listing →
  • Terminated NCT NCT05301192

    Angiotensin-(1-7) Cardiovascular Effects in Aging

    Not yet reported Milton S. Hershey Medical Center 4 participants Est. completion 2024-06-10 1 site Stand-alone
    Other conditions: Aging
    View official trial listing →
  • Status unknown NCT NCT05322200

    The POST-ACS Study

    Not yet reported Swansea Bay University Health Board 140 participants Est. completion 2024-08-01 1 site
    Cardiovascular disease Other conditions: Diabetes Mellitus, Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT05329727

    The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF

    Wonju Severance Christian Hospital 1000000 participants Est. completion 2025-12-31 1 site
    Heart failure Other conditions: Mortality
    View official trial listing →
  • Active, not recruiting NCT NCT05331144

    Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

    Not yet reported Rong Zhang 180 participants Est. completion 2028-08-31 1 site Stand-alone
    Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Dementia
    View official trial listing →
  • Status unknown NCT NCT05336175

    Biomarker Study: Heart Failure Patients at Risk

    Not yet reported, Not yet reported University of Arizona 40 participants Est. completion 2023-12 2 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05364190

    Canagliflozin in Patients With Acute Decompansted Heart Failure

    Not yet reported October 6 University 142 participants Est. completion 2024-03-01 1 site Stand-alone
    Heart failure Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT05366101

    Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy

    Not yet reported, Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 168 participants Est. completion 2022-03-31 1 site
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Status unknown NCT NCT05373004

    Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease

    Not yet reported, Not yet reported Omar Tarek Elfarargi 212 participants Est. completion 2024-05
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT05387967

    Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction

    Not yet reported National Institute of Cardiovascular Diseases, Pakistan 121 participants Est. completion 2021-09-30 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05398731

    Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Risk of COVID_19

    Assiut University 400 participants Est. completion 2023-05
    Other conditions: COVID-19 Pneumonia
    View official trial listing →
  • Completed NCT NCT05418361

    The Effect of RAAS Blockers on ACE2 Levels

    Ain Shams University 100 participants Est. completion 2022-02-20 1 site
    Other conditions: Renin-Angiotensin System
    View official trial listing →
  • Completed NCT NCT05419583

    Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction

    Not yet reported University of Edinburgh 60 participants Est. completion 2024-06-30 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05427253

    First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

    Not yet reported Vicore Pharma AB 80 participants Est. completion 2023-06-22 1 site Stand-alone
    Other conditions: Safety Issues, Tolerance, Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT05464745

    Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers

    Not yet reported Darnitsa Pharmaceutical Company 42 participants Est. completion 2021-06-09 1 site Stand-alone
    Other conditions: Bioequivalence, Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05470764

    Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

    Not yet reported Darnitsa Pharmaceutical Company 52 participants Est. completion 2021-06-28 1 site Stand-alone
    Other conditions: Bioequivalence, Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05498181

    Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation

    Not yet reported Brigham and Women's Hospital 45 participants Est. completion 2026-01-31 1 site
    Other conditions: Hemodialysis
    View official trial listing →
  • Status unknown NCT NCT05516511

    Serum Levels of Angiotensin Converting Enzyme in Systemic Lupus Erythematous Patients

    Sohag University 75 participants Est. completion 2023-03 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT05535595

    Precision Treatment With Angiotensin Converting Enzyme Inhibitor

    Not yet reported Yonsei University 77 participants Est. completion 2021-08-02 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT05593770

    International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

    Not yet reported, Not yet reported NEAT ID Foundation 28 participants Est. completion 2023-12-14 21 sites
    Other conditions: COVID-19, SARS-CoV2 Infection, Coronavirus Infection
    View official trial listing →
  • Status unknown NCT NCT05623358

    PHARM Optimal-HF Pilot

    Not yet reported University of British Columbia 42 participants Est. completion 2025-09-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT05633758

    Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure

    Not yet reported Scripps Health Est. completion 2016-03 1 site
    Heart failure
    View official trial listing →
  • Active, not recruiting NCT NCT05637216

    Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

    Not yet reported Shaw Cancer Center 43 participants Est. completion 2027-08-17 1 site
    Other conditions: Radiation Induced Fibrosis
    View official trial listing →
  • Active, not recruiting NCT NCT05637853

    Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction

    Not yet reported Göteborg University 60 participants Est. completion 2026-08-26 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05638880

    Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease

    Not yet reported Mostafa Bahaa 60 participants Est. completion 2025-12-20 1 site Stand-alone
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Status unknown NCT NCT05644769

    Chymase Angiotensin-(1-12) Axis In Hypertensive Disease

    Not yet reported Trinity Hypertension & Metabolic Research Institute 10 participants Est. completion 2023-03-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05709444

    A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

    Not yet reported Palatin Technologies, Inc 16 participants Est. completion 2024-04-26 9 sites
    Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT05711810

    Medicine-induced Cardiac Hemodialysis on COVID-19

    Not yet reported Yang I. Pachankis 1 participants Est. completion 2023-01-12 1 site Stand-alone
    Other conditions: Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines, Myocarditis Allergic, Infection Viral
    View official trial listing →
  • Status unknown NCT NCT05745571

    Molecular Pathways of Cardiac Remodellation in Patients With Acute and Chronic Left Ventricular Disfunction

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90 participants Est. completion 2023-12-10 1 site
    Heart failure Other conditions: Ischemic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT05759754

    Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease

    Not yet reported Children's Hospital of Fudan University 72 participants Est. completion 2024-12-01 9 sites Stand-alone
    Other conditions: Proteinuria, Kidney Diseases, Hereditary Nephropathy
    View official trial listing →
  • Status unknown NCT NCT05782881

    High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 16000 participants Est. completion 2024-12-31 107 sites
    Cardiovascular diseaseType 2 diabetes Other conditions: Coronary Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05806138

    A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

    Not yet reported Memorial Sloan Kettering Cancer Center 21 participants Est. completion 2028-07-17 1 site
    Other conditions: Breast Cancer, Cardiac Dysfunction
    View official trial listing →
  • Status unknown NCT NCT05818995

    Therapeutic Drug Use for CKD Patients

    Qianfoshan Hospital 10000 participants Est. completion 2024-06-30 1 site
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT05824390

    A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy

    Not yet reported XIEJINGYUAN 116 participants Est. completion 2023-10-01 1 site Stand-alone
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT05824767

    Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock

    Not yet reported University of New Mexico 42 participants Est. completion 2025-03-12 1 site Stand-alone
    Other conditions: Septic Shock, Vasodilatory Shock
    View official trial listing →
  • Active, not recruiting NCT NCT05824923

    A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

    Not yet reported Pulnovo Medical (Wuxi) Co., Ltd. 264 participants Est. completion 2027-02 1 site Stand-alone
    Heart failureCardiovascular disease Other conditions: Pulmonary Hypertension, Hypertension, Vascular Diseases
    View official trial listing →
  • Completed NCT NCT05831644

    A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes

    Not yet reported Vicore Pharma AB 11 participants Est. completion 2023-06-20 1 site Stand-alone
    Other conditions: Type2diabetes, Endothelial Dysfunction
    View official trial listing →
  • Status unknown NCT NCT05839236

    COVID-19 Vaccination Detoxification in LDL-C

    Not yet reported Yang I. Pachankis 1 participants Est. completion 2023-07-31 1 site Stand-alone
    Cardiovascular disease Other conditions: COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction, COVID-19-Associated Thromboembolism, COVID-19 Post-Intensive Care Syndrome, COVID-19 Respiratory Infection
    View official trial listing →
  • Completed NCT NCT05841498

    Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome

    Not yet reported University Medical Center Mainz 40 participants Est. completion 2025-05-12 1 site
    Other conditions: Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition
    View official trial listing →
  • Not yet recruiting NCT NCT05865665

    Registry Of Best Up-titration STrategies in Acute Heart Failure

    Heart Initiative 5000 participants Est. completion 2027-12
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05873400

    Effect of Renin Angiotensin Aldosterone System Genetic Polymorphism on the Pharmacological Effect of Mineralocorticoid Receptor Antagonists in Patients With Myocardial Infarction

    Ain Shams University 102 participants Est. completion 2024-04-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT05893108

    Ethosomal Gel Bearing Losartan 5% for Keloid Treatment

    Not yet reported, Not yet reported Yuni Eka Anggraini 46 participants Est. completion 2024-10-30 1 site
    Other conditions: Keloid
    View official trial listing →
  • Terminated NCT NCT05897372

    Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study

    Not yet reported Iain Bressendorff 1 participants Est. completion 2024-09-23 1 site
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT05922852

    Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein

    Peking University Third Hospital 1000 participants Est. completion 2024-02-28 2 sites
    Type 2 diabetes Other conditions: Antidiabetic Drugs
    View official trial listing →
  • Status unknown NCT NCT05948969

    Transform CV Risk in Diabetes

    Not yet reported American College of Cardiology 750 participants Est. completion 2024-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05966818

    Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.

    Not yet reported Ain Shams University 90 participants Est. completion 2024-03-01
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Status unknown NCT NCT05972785

    Long-term Use of CCB and Breast Cancer Risk

    Curtin University 68500 participants Est. completion 2025-12 1 site
    Other conditions: Hypertension,Essential, Breast Cancer
    View official trial listing →
  • Completed NCT NCT05989503

    Initiation of ARNi and SGLT2i in Patients With HFrEF

    Not yet reported Universidade do Porto 62 participants Est. completion 2025-07-31 5 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT05990296

    Evaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure Care

    Not yet reported Geisinger Clinic 4306 participants Est. completion 2025-05-17 1 site
    Heart failure
    View official trial listing →
  • Not yet recruiting NCT NCT06012487

    Correlates and Control of Blood Pressure Variability

    Not yet reported Cedars-Sinai Medical Center 10 participants Est. completion 2026-12-31
    Other conditions: Blood Pressure Variability
    View official trial listing →
  • Status unknown NCT NCT06013839

    TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy

    Not yet reported Constant Therapeutics LLC 10 participants Est. completion 2024-12 2 sites Stand-alone
    Other conditions: DMD-Associated Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT06026787

    Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

    Not yet reported Ain Shams University 60 participants Est. completion 2023-08-01 1 site Stand-alone
    Other conditions: Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors
    View official trial listing →
  • Completed NCT NCT06046924

    Dietary Acid Reduction and Progression of Chronic Kidney Disease

    Not yet reported Donald Wesson 153 participants Est. completion 2011-12-15 Stand-alone
    Chronic kidney diseaseCardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT06055673

    Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases in Sohag Hospital University.

    Sohag University 182 participants Est. completion 2023-12-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06072508

    Prognostic Interest of Vasorin in Septic Shock

    Not yet reported Centre Hospitalier Universitaire, Amiens 50 participants Est. completion 2025-03-29 1 site
    Other conditions: Sepsis, Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT06088849

    Maternal Treatment With ACE-inhibitors and Breastfeeding: a Mono-centric Study on the Exposure Through Breast Milk

    Not yet reported Universitaire Ziekenhuizen KU Leuven 20 participants Est. completion 2023-12-31 1 site
    Heart failure Other conditions: Breast Feeding, Hypertension, Proteinuria
    View official trial listing →
  • Status unknown NCT NCT06090617

    Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn

    University Hospital Padova 35 participants Est. completion 2025-01-01 1 site
    Other conditions: Hyperaldosteronism, Hypertension, Aldosterone-producing Adenoma, Aldosteronism, Aldosterone Disorder, Essential Hypertension, Bilateral Adrenal Hyperplasia, Conn Adenoma
    View official trial listing →
  • Completed NCT NCT06093971

    Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

    Not yet reported Yonsei University 112 participants Est. completion 2024-10-22 1 site
    Other conditions: Prostate Tumor
    View official trial listing →
  • Completed NCT NCT06096077

    Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department

    Methodist Health System 50 participants Est. completion 2023-08-23 1 site
    Other conditions: Angioedema
    View official trial listing →
  • Completed NCT NCT06101667

    Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)

    Not yet reported Beijing Tiantan Hospital 224 participants Est. completion 2026-07-01 1 site
    Cardiovascular disease Other conditions: Basilar Artery Occlusion
    View official trial listing →
  • Status unknown NCT NCT06109142

    Clearance of Vasoactive Metabolites With Blood Purification

    Assistance Publique - Hôpitaux de Paris 30 participants Est. completion 2026-06-11 3 sites
    Other conditions: Critically Ill Patients
    View official trial listing →
  • Status unknown NCT NCT06122987

    Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock

    Not yet reported Kingman Regional Medical Center 50 participants Est. completion 2025-01 1 site Stand-alone
    Other conditions: Septic Shock, Shock, Sepsis, Systemic Inflammatory Response Syndrome
    View official trial listing →
  • Status unknown NCT NCT06135103

    Phase 2 Study of TXA127 in Post-ischemic Stroke Patients

    Not yet reported Constant Therapeutics LLC 50 participants Est. completion 2025-09 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06155812

    Multimodal Vasopressor Strategy in Septic Shock

    Not yet reported, Not yet reported University Medical Centre Maribor 79 participants Est. completion 2026-02-01 2 sites Stand-alone
    Other conditions: Shock, Septic
    View official trial listing →
  • Completed NCT NCT06157580

    Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia

    Not yet reported Anna Stanhewicz, PhD 24 participants Est. completion 2024-12-10 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Status unknown NCT NCT06175663

    Hyperintense: Midlife Hypertension and the Brain

    Radboud University Medical Center 130 participants Est. completion 2023-12-31 1 site
    Other conditions: Hypertension, Small Vessel Cerebrovascular Disease
    View official trial listing →
  • Completed NCT NCT06185660

    A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

    AstraZeneca 125 participants Est. completion 2025-01-03 10 sites
    Other conditions: Hyperkalaemia
    View official trial listing →
  • Status unknown NCT NCT06187493

    Treatment of Patients With Diabetic Kidney Disease

    Not yet reported Assiut University 70 participants Est. completion 2025-12-31
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT06201000

    Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients

    October 6 University 282 participants Est. completion 2024-09-01 1 site
    Heart failure Other conditions: Genetic Polymorphisms
    View official trial listing →
  • Completed NCT NCT06247371

    Impact of a Novel Heart Failure Medication Decision Aid

    Not yet reported National University of Singapore 150 participants Est. completion 2025-02-10 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT06253429

    Alpha-lipoic Acid in Diabetic Nephropathy

    Not yet reported Ain Shams University 30 participants Est. completion 2024-02-01 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT06272487

    Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

    Not yet reported Alnylam Pharmaceuticals 375 participants Est. completion 2025-12-01 195 sites
    Other conditions: High Cardiovascular Risk, Hypertension
    View official trial listing →
  • Status unknown NCT NCT06278727

    Development and Validation of the Prediction Model for Functional Mitral Regurgitation Regression in Heart Failure Patients Taking Guideline-directed Medical Therapy

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 270 participants Est. completion 2025-12-31 1 site
    Heart failure Other conditions: Mitral Regurgitation
    View official trial listing →
  • Completed NCT NCT06291883

    Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

    Not yet reported Sheng-Teng Huang 26 participants Est. completion 2024-02-08 1 site
    Other conditions: Coronavirus Disease 2019, Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    View official trial listing →
  • Status unknown NCT NCT06295393

    Renin Angiotensin Aldosterone System In Septic Kids

    Northwell Health 74 participants Est. completion 2025-06-01 1 site
    Other conditions: Sepsis, Acute Kidney Injury Due to Sepsis, Acute Kidney Injury (Nontraumatic)
    View official trial listing →
  • Status unknown NCT NCT06304896

    Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy

    Not yet reported Arab Contractors Medical Centre 150 participants Est. completion 2025-12-01 1 site
    Other conditions: Chemotherapy Induced Systolic Dysfunction
    View official trial listing →
  • Completed NCT NCT06382571

    Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients

    Chulalongkorn University 396 participants Est. completion 2021-12-31
    Heart failure
    View official trial listing →
  • Completed NCT NCT06395194

    Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

    Not yet reported Oslo University Hospital 15313 participants Est. completion 2003-12-05
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT06417320

    Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years

    Not yet reported Mansoura University 60 participants Est. completion 2025-08 1 site
    Other conditions: Nephrotic Syndrome in Children
    View official trial listing →
  • Completed NCT NCT06423352

    A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

    Not yet reported, Not yet reported Alnylam Pharmaceuticals 36 participants Est. completion 2025-07-17 3 sites
    Other conditions: Mild to Moderate Hypertension
    View official trial listing →
  • Completed NCT NCT06425705

    Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors

    Not yet reported Lahore General Hospital 70 participants Est. completion 2023-07-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06499948

    Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT)

    Not yet reported Stefan Lujinschi 12 participants Est. completion 2026-04-30 1 site Stand-alone
    Other conditions: Alport Syndrome, Thin Basement Membrane Disease, Alport Nephropathy
    View official trial listing →
  • Completed NCT NCT06500000

    The Plasma Metabolomics Profiling of Primary Aldosteronism

    Third Military Medical University 95 participants Est. completion 2023-05-19 1 site
    Other conditions: Primary Aldosteronism, Essential Hypertension, Idiopathic Aldosteronism, Aldosterone-producing Adenoma
    View official trial listing →
  • Status unknown NCT NCT06501651

    Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

    Not yet reported Sichuan Academy of Medical Sciences 297 participants Est. completion 2025-04-10 1 site Stand-alone
    Type 2 diabetes Other conditions: Essential Hypertension, Nephropathy
    View official trial listing →
  • Status unknown NCT NCT06515678

    Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

    Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
    Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
    View official trial listing →
  • Status unknown NCT NCT06532682

    Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 54 participants Est. completion 2026-10-01 1 site
    Chronic kidney disease Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT06555146

    Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy

    Not yet reported Bispebjerg Hospital 15 participants Est. completion 2025-03 1 site
    Type 2 diabetes Other conditions: Kidney Disease, Chronic
    View official trial listing →
  • Active, not recruiting NCT NCT06588686

    A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Not yet reported Vicore Pharma AB 378 participants Est. completion 2027-06 104 sites
    Other conditions: Idiopathic Pulmonary Fibrosis (IPF)
    View official trial listing →
  • Completed NCT NCT06604897

    Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

    Novartis Pharmaceuticals 1405 participants Est. completion 2025-10-31 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Withdrawn NCT NCT06608472

    Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

    Not yet reported Eurofarma Laboratorios S.A. Est. completion 2029-10-30
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT06624904

    Losartan and Social Processing

    Not yet reported University of Oxford 68 participants Est. completion 2025-10-01 1 site
    Other conditions: Social Cognition
    View official trial listing →
  • Status unknown NCT NCT06635616

    Hypertension Management in Terms of Routine Agents

    Saglik Bilimleri Universitesi 350 participants Est. completion 2025-11-01 2 sites
    Other conditions: Hypertension, Emergency Medicine
    View official trial listing →
  • Not yet recruiting NCT NCT06660940

    Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy

    Not yet reported Chinese PLA General Hospital 460 participants Est. completion 2027-10 Stand-alone
    Chronic kidney disease Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Status unknown NCT NCT06679426

    Safety and Efficacy of Conestat Alfa for ACE-Induced Angioedema

    Not yet reported University of Cincinnati 24 participants Est. completion 2025-12
    Other conditions: ACE Inhibitor-Induced Angioedema
    View official trial listing →
  • Completed NCT NCT06683768

    A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve Hypertension

    Novartis Pharmaceuticals 40563 participants Est. completion 2023-11-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT06690723

    Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea

    Not yet reported University Malaysia Sarawak 160 participants Est. completion 2024-09-03 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT06697353

    An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan

    Bayer 4936 participants Est. completion 2025-09-19 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT06700213

    Guideline Directed Medical Therapy in Patients With Heart Failure

    Massachusetts General Hospital 300 participants Est. completion 2025-09-22 1 site
    Heart failure
    View official trial listing →
  • Not yet recruiting NCT NCT06712030

    Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction

    Not yet reported Puerta de Hierro University Hospital 114 participants Est. completion 2027-06 1 site
    Other conditions: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
    View official trial listing →
  • Not yet recruiting NCT NCT06746753

    Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock

    Not yet reported Wake Forest University Health Sciences 78 participants Est. completion 2028-10-07 2 sites Stand-alone
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT06764277

    Mechanisms and Phenotypes of Hypertension in Patients in Chronic Hemodialysis

    Bernardo Rodríguez Iturbe 32 participants Est. completion 2025-06-06 1 site
    Other conditions: Arterial Hypertension, Hemodialysis
    View official trial listing →
  • Not yet recruiting NCT NCT06794710

    Early Identification and Treatment of Rare Cardiomyopathy Cohorts

    Not yet reported RenJi Hospital 300 participants Est. completion 2027-09-30 1 site Stand-alone
    Other conditions: Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Metabolic Cardiomyopathy, Restrictive Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT06862115

    The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery

    Not yet reported Kasr El Aini Hospital 182 participants Est. completion 2026-08-10 1 site
    Other conditions: Myocardium; Injury, Perioperative/Postoperative Complications, Angiotensin-Converting-Enzyme Inhibitor
    View official trial listing →
  • Active, not recruiting NCT NCT06895213

    Evaluation of Plasma Renin Concentrations in Cardiac Surgery

    Mayo Clinic 100 participants Est. completion 2026-12 1 site
    Other conditions: Cardiac Surgery With Cardiopulmonary Bypass
    View official trial listing →
  • Completed NCT NCT06915870

    Comparison of Empagliflozin and Dapagliflozin in Patients With Heart Failure Taking Standard Treatment

    Not yet reported Fatima Maqsood 108 participants Est. completion 2025-01-13 1 site
    Heart failure Other conditions: Diabetes Mellitus
    View official trial listing →
  • Not yet recruiting NCT NCT06964217

    Immediate Fracture Risk After Antihypertensive Drug Initiation

    Ajou University School of Medicine 10000000 participants Est. completion 2025-07-31
    Other conditions: Hypertension, Fracture
    View official trial listing →
  • Completed NCT NCT07012538

    RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer

    Fudan University 2640 participants Est. completion 2025-04-30 1 site
    Other conditions: Colon Cancer (Stage II &Amp;Amp; III)
    View official trial listing →
  • Completed NCT NCT07023016

    Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure

    Not yet reported, Not yet reported National Heart Institute, Egypt 515 participants Est. completion 2025-02-28 2 sites
    Heart failureChronic kidney disease
    View official trial listing →
  • Not yet recruiting NCT NCT07032116

    YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

    Liu Hongfang 4472 participants Est. completion 2028-07-31 5 sites
    Chronic kidney disease
    View official trial listing →
  • Not yet recruiting NCT NCT07044700

    Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction

    Boehringer Ingelheim 5000 participants Est. completion 2028-12-31 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT07088471

    Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan

    Connolly Hospital Blanchardstown 334 participants Est. completion 2025-08-01 1 site
    Heart failure
    View official trial listing →
  • Active, not recruiting NCT NCT07098897

    To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy

    Not yet reported The Affiliated Hospital of Xuzhou Medical University 150 participants Est. completion 2025-09-30 1 site
    Other conditions: IgA Nephropathy (IgAN)
    View official trial listing →
  • Enrolling by invitation NCT NCT07181135

    FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

    Not yet reported University Medical Center Groningen 180 participants Est. completion 2027-12-31 8 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT07184918

    Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography

    Not yet reported Tanta University 44 participants Est. completion 2025-06-01 1 site
    Other conditions: Contrast-Induced Nephropathy, Coronary Angiography, Acute Kidney Injury
    View official trial listing →
  • Enrolling by invitation NCT NCT07212686

    Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension

    Not yet reported Todd Sweberg 30 participants Est. completion 2030-06 2 sites Stand-alone
    Other conditions: Vasodilatory Shock
    View official trial listing →
  • Not yet recruiting NCT NCT07241338

    Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity

    Not yet reported Jing Liu 104 participants Est. completion 2027-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07261098

    The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension

    Not yet reported Shanghai Chest Hospital 200 participants Est. completion 2028-12-31
    Other conditions: Advanced Lung Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07262723

    Levosimendan in Acute Decompensated Heart Failure

    Not yet reported, Not yet reported Chittagong Medical College 332 participants Est. completion 2026-12-30 6 sites
    Heart failure
    View official trial listing →
  • Enrolling by invitation NCT NCT07292493

    Immune System in Diabetic Kidney Disease

    University Medical Centre Ljubljana 90 participants Est. completion 2028-12 1 site
    Chronic kidney disease Other conditions: Diabetes, Complement System
    View official trial listing →
  • Not yet recruiting NCT NCT07295522

    Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?

    Not yet reported IRCCS Policlinico S. Donato 368 participants Est. completion 2028-06-08 13 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT07315139

    Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients

    Not yet reported Ain Shams University 42 participants Est. completion 2023-08-31 1 site
    Chronic kidney disease Other conditions: Pentoxifylline, Inflammatory Markers, Non-Diabetic
    View official trial listing →
  • Not yet recruiting NCT NCT07349979

    PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF

    Not yet reported Nanjing First Hospital, Nanjing Medical University 1154 participants Est. completion 2028-01-30 1 site
    Heart failureCardiovascular disease Other conditions: Stable GDMT
    View official trial listing →
  • Completed NCT NCT07374484

    Longitudinal Dynamics of AT1R Antibodies in Kidney Transplant Recipients

    Seoul National University Hospital 241 participants Est. completion 2025-12-09 1 site
    Other conditions: Kidney Transplantation, Graft Survival, Angiotensin II Type 1 Receptor Antibody
    View official trial listing →
  • Not yet recruiting NCT NCT07447206

    Vascular Intervention Strategies Trial for Alzheimer's

    Not yet reported University of Southern California 10 participants Est. completion 2028-06 1 site Stand-alone
    Other conditions: Hypertension, Hypercholesterolemia, Dementia Risk Factors
    View official trial listing →
  • Not yet recruiting NCT NCT07465666

    A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates

    Novartis Pharmaceuticals 500 participants Est. completion 2027-08-31
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT07512661

    The Relationship Between Serum and Urinary Angiotensinogen Levels and Long-Term Renal Prognosis in Acute Renal Injury

    Sanliurfa Mehmet Akif Inan Education and Research Hospital 80 participants Est. completion 2026-03-01 1 site
    Other conditions: In Acute Kidney Injury
    View official trial listing →
  • Enrolling by invitation NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT07568275

    Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance

    Not yet reported The Cleveland Clinic 30 participants Est. completion 2028-01 1 site
    Other conditions: Septic Shock, Cirrhosis, Vasodilatory Shock, Acute Kidney Injury
    View official trial listing →
  • Not yet recruiting NCT NCT07583992

    Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia

    Not yet reported National Research Institute of Chinese Medicine, Ministry of Health and Welfare 150 participants Est. completion 2027-11 1 site Stand-alone
    Other conditions: Mild to Moderate, Community-Acquired Pneumonia (CAP), Antibiotic Therapy, Intravenous, Hospitalisation
    View official trial listing →
  • Not yet recruiting NCT NCT07602166

    Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans

    Not yet reported Vanderbilt University Medical Center 20 participants Est. completion 2031-07 1 site
    Other conditions: Salt Sensitivity of Blood Pressure, High Blood Pressure, Inflammation, Renin-Angiotensin-Aldosterone System
    View official trial listing →
  • Not yet recruiting NCT NCT07605390

    RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)

    Not yet reported Baylor Research Institute 600 participants Est. completion 2028-01 2 sites
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Completed NCT NCT07666607

    Pathological Mechanism Study of Aerobic Exercise Regulating Cold Stress-induced Hypertension Via the Thermosensitive Target-mediated Sympathetic Nerve Pathway

    Wang Jingfeng 200 participants Est. completion 2025-12-28 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07671365

    Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)

    Not yet reported Methodist Healthcare System of San Antonio 329 participants Est. completion 2030-08 Stand-alone
    Other conditions: Vasoplegic Shock, Cardiopulmonary Bypass, Vasoplegia
    View official trial listing →
  • Not yet recruiting NCT NCT07675291

    Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children

    Not yet reported Nanfang Hospital, Southern Medical University 112 participants Est. completion 2028-12-31
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Not yet recruiting NCT NCT07678021

    Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction

    Not yet reported China National Center for Cardiovascular Diseases 452 participants Est. completion 2029-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07681726

    Project HOPE (Hypertension Outreach Through Partnership and Engagement)

    Johns Hopkins University 150 participants Est. completion 2027-09-30 1 site
    Other conditions: Hypertension (HTN)
    View official trial listing →
  • Completed NCT NCT07721428

    Salivary Angiotensin-Converting Enzyme and Periodontal Disease in Cardiovascular Disease

    Suleyman Demirel University 76 participants Est. completion 2026-06-01 1 site
    Cardiovascular disease Other conditions: Periodontal Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07721974

    Alterations of the Renin-angiotensin-aldosterone System in sEptic Shock

    Not yet reported Assistance Publique - Hôpitaux de Paris 320 participants Est. completion 2031-10
    Other conditions: Septic Shock
    View official trial listing →
  • Not yet recruiting NCT NCT07735130

    Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)

    Not yet reported Seoul National University Hospital 632 participants Est. completion 2030-06-15 1 site Stand-alone
    Other conditions: Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy, Severe Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT07746908

    Bioequivalence Study of Valsatril Tablet Versus Entresto® Sacubitril/Valsartan 24/26 mg Tablet.

    Not yet reported Center for Bioequivalence Studies and Clinical Research 60 participants Est. completion 2025-07-18 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07757048

    A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United States

    Novartis Pharmaceuticals 6286 participants Est. completion 2026-07-01 1 site
    Other conditions: IGA Nephropathy
    View official trial listing →
  • Not yet recruiting NCT NCT07770815

    Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 24 participants Est. completion 2030-02-23 Stand-alone
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Not yet recruiting NCT NCT07775846

    QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy

    Not yet reported Huijie Zhang 820 participants Est. completion 2029-06-30 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Not yet recruiting NCT NCT07828223

    Cardiac Improvement by Eplerenone Among Patients Under Cyclosporine or Tacrolimus for Kidney Transplantation.

    Not yet reported Central Hospital, Nancy, France 132 participants Est. completion 2030-12 3 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT07832942

    Beta-2 Adrenergic Receptor Polymorphic Variants: An Endotype of Salt Sensitive Hypertension (Beta2AR).

    Not yet reported Brigham and Women's Hospital 110 participants Est. completion 2030-04 1 site Stand-alone
    Other conditions: Genetics in Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07841522

    A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HW243040 in Healthy Participants

    Not yet reported The Third Xiangya Hospital of Central South University 98 participants Est. completion 2027-07-31
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT07856043

    [11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction

    Not yet reported Stony Brook University 18 participants Est. completion 2028-12-31 1 site Stand-alone
    Heart failure Other conditions: Cognitive Impairment, Mild, Neuroinflammation, Vascular Contributions to Cognitive Impairment and Dementia (VCID)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Angiotensin Ii, Angiotensin, Angiotensin-(1-7), Angiotensin I/II (1-7) Acetate

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.